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The most abundant pathological protein in the debilitating 
neurodegenerative disease, Amyotrophic Lateral Sclerosis (ALS) is TDP-
43. Knock-down of its Drosophila homologue TBPH, recapitulates the 
disease in fly, with mutants showing reduced life span and locomotion 
impairment among other features. These can be restored by expressing 
human TDP-43 both in neurons and glial cells. It has been observed in 
TBPH mutants a reduction of the Futsch protein, the homologue of the 
human MAP1B responsible for the stabilization of the synaptic 
microtubule cytoskeleton during growth at the neuromuscular junction. 
We used our Drosophila model of ALS to investigate the role of Futsch in 
the rescue of locomotion defects observed in the disease using the UAS-
GAL4 system. Futsch expression in TBPH mutants using both pan-
neuronal and motor neuron-specific drivers show a significant rescue of 
larval motility. The synaptic organization defect observed in the mutants 
was recovered through the restoration of the synaptic branches, boutons 
and shape. Also some synaptic and vesicle proteins such as Dlg, 
Synapsin, Syntaxin, Csp and acetylated tubulin were recovered. The 
defect in the cycling of synaptic vesicles and the level of the BMP signal 
transducer, pMad were ameliorated by the expression of Futsch in TBPH 
mutants. It is interesting to note that TBPH mutants expressing the 
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GTPases Rab4 and Rab5, which are vesicle proteins associated with 
endosomal trafficking and recycling, were able to recover the levels of 
Futsch, acetylated tubulin and synaptic pMad. However, only Rab4 gave 
also a functional recovery of improved locomotion despite its reduced 
expression level compared to Rab5. We conclude that improved synaptic 
vesicle recycling system and enhanced BMP growth signalling are parts 
of the mechanisms involved in the recovery of locomotion defects 
observed in TBPH mutants expressing Futsch. We speculate that this 
recovery may be achieved through the functional anatomical recovery of 
the synaptic organization at the neuromuscular junction via the enhanced 
BMP growth signalling. Also included in the speculation is improved 
neurotransmission at the synaptic terminals resulting from the recovered 
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mutant) and EP10751; tbph∆23elav-gal4/tbph∆23 (Futsch rescue). Error 
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1.1 Amyotrophic Lateral Sclerosis (ALS)  
ALS is a fatal, rapidly progressing neurodegenerative disease that  is 
specific to the motor neurons. It has an incidence spanning from about 
0.43 to 2.35 per 100,000 people in Asia and western Europe respectively. 
Statistically, men are more affected than women and peak disease is 
reached at 60-70 years (Palese et al., 2019). While in 90-95% of cases it 
appears as sporadic starting around 60 years of age, there are also 
familial cases in 5-10% of all patients with an earlier onset starting around 
50 years (Al-Chalabi et al., 2017).  
The late French Neurologist, Jean-Martin Charcot was credited to be the 
first person to use the term Amyotrophic lateral sclerosis to refer to the set 
of neurological symptoms of the disease in 1874 but they have been 
described earlier in 1824 by Charles Bells (Rowland & Shneider, 2001). 
The prognosis is 2-4 years from diagnosis and the majority die of 
respiratory failure, which is a consequence of the disease that is preceded 
by muscle stiffness, paralysis, deformed joints with pain, difficulties in 
eating, swallowing, talking, walking and also breathing (Hobson & 
McDermott, 2016). Although, there are some reported cases of cognitive 
decline in sporadic ALS (Chiang et al., 2010) Usually, the cognitive 
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function is preserved being the hallmark that differentiates ALS from 
Fronto-Temporal Lobar Degeneration (FTLD).  
About 75% of patients present a limb-onset with symptoms typically 
starting from the arms, beginning with loss of manual dexterity and 
weakness of the limbs, and ending with foot drop and difficulty in walking. 
Cases of bulbar onset of ALS have been reported in older women with a 
consequent worse prognosis of the disease. The symptoms include 
dysarthria to anarthria, twitching of the tongue which is a classic 
characteristic, head drop and poor balance (Chiò et al., 2009; Gordon, 
2013). 
                               
Figure 1: ALS progress showing affected nerve and muscle areas. It is thought to start in the upper 
motor neurons in the motor cortex and brainstem and reaches the voluntary muscles of the tongue, 




Why both upper and lower motor neurons (Figure 1) are particularly 
susceptible to the disease is not clear but it could be that defects in 
microtubule structure and presumably axonal transport result in a 
devastating insult to these kind of cells. Some motor neurons have the 
longest axonal projections in the body with most lacking buffering capacity 
(Poulain & Sobel, 2010). Also, they are comparatively large excitable cells 
with high energy demands in close association with non-neuronal cells 
(Robberecht & Philips, 2013). 
1.1.2 Pathogenesis of ALS  
Several gene mutations have been linked with ALS and they include: 
C9orf72 (which encodes chromosome 9 open reading frame 72), Sod1 
(Superoxide dismutase 1) (Kunst et al., 1997), Fus (fused in sarcoma) 
(Vance et al., 2009), Tbk1 (TANK-binding kinase 1), (Oakes et al., 2017),  
Vcp (Valosin-containing protein) (Koppers et al., 2012), Ubqln2 & Ubqln4  
(Ubiquilin 2 & 4) (H. X. Deng et al., 2011; Edens et al., 2017), Nek1 
(NEMA-like kinase 1) (Brenner et al., 2016), Optn (Optineurin) (Maruyama 
et al., 2010), Pfn1 (Profilin 1) (Tanaka et al., 2016), Matr3 (Matrin 3) 
(Johnson et al., 2014), Kif5a (Kinesin heavy chain isoform 5A) (Nicolas et 
al., 2018), Setx (Senataxin) (M. Hirano et al., 2011) and the TDP-43 gene 
(Tardp), among others (Van Damme et al., 2017).  Of all these genes, the 
most frequently occurring mutations are in C9orf72, Sod1, Fus and Tdp-
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43 (Figure 2)  (Vijayakumar et al., 2019). Only TDP-43 is within the scope 
of this study. 
            
Figure 2 Schematic representation of the most frequently occurring gene mutations in familial 
and sporadic amyotrophic lateral sclerosis (Adapted from Zou et al., 2017). 
 
1.1.3 Treatment and Management of ALS 
Till date, ALS has no known cure so, care is palliative. Riluzole (2-
aminotrifluoromethoxybenzotiazole) is used to slow down the progression 
of the disease and it prolongs survival for approximately three months. 
Riluzole acts by blocking sodium channels preventing the release of 
glutamate, excess of which leads to excitotoxicity (Figure 3). Glutamate-
induced excitotoxicity leads to neuronal injury causing death of the neuron 





      
Figure 3 The structure and mode of action of riluzole. A) The chemical structure of riluzole. B) 
Riluzole is able to prevent glutamate excitotoxicity by blocking its release from the neurons and 
promoting its uptake by glial cells. Thus, its action is neuroprotective. C) Structure of Edaravone, it 
exerts both antioxidant and neuroprotective effects. Adapted from www.mdpi.com 
 
The drug Edaravone (2,4-dihydro-3H-pyrazol-3-one) is a potent 
antioxidant and has recently come in use. Not only does it scavenges free 
radicals in neurons, it is also able to slow down the disease progression 
by limiting the extent of lipid peroxidation via free radical generation and 
the cell membrane damage from oxidative stress (Janke & Montagnac, 
2017). While research into ALS cure is on-going, the management of ALS 
patients is based on prolonging patients’ life and also maintaining certain 
qualities of life by a specialized care team. This team is  composed of 
cross-disciplinary clinics, medications that are neuroprotective, 
therapeutic symptomatic relieve and respiratory support (Gordon, 2013).   
1.1.4 Molecular mechanisms of ALS  
ALS is cellularly characterized by loss of motor neurons’ cell bodies, 
axonal retraction and gliosis (proliferation of glial cells forming scar tissue 
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in response to an insult or injury in the brain). Surviving neurons contain 
inclusions that are ubiquitin and p62 positive. Figure 4 summarizes the 
proposed mechanisms involved in ALS, which is truly a heterogenic 
disease with numerous contributing factors and associating mechanisms. 
Among the several mechanisms, alterations in nucleocytoplasmic 
transport of RNA molecules and RNA-binding proteins are suggested as 
disease-causing. This is because several mutations have been identified 
in many nucleo-cytoplasmic shuttling RNA-DNA binding proteins such as 
TDP-43 and FUS proteins that are implicated in the disease among 
others. Also a mis-localization of proteins from nucleus to cytoplasm, 
inducing nuclear depletion and cytoplasmic aggregation is a further 
mechanism proposed. The resulting loss of function in the nucleus and 
gain of function in the cytoplasm are thought to be detrimental to the cell 
especially for  TDP-43, FUS, ATXN2 and  hnRNPA1/A2 proteins. Increase 
in oxidative stress and reactive oxygen species contribute to the pathology 
of ALS. Several ALS-related proteins (SOD1, TDP-43, C9orf72) are able 
to move into the mitochondria altering its functions and resulting in 
impairment (Lezi & Swerdlow, 2012). Axonal transport defects are also 
implicated and are caused by disruption in axonal structure and function 
as a result of functional disorganization of cytoskeletal proteins. (Van 
damme et al., 2017). Also alterations in the transport of vesicles have 
been suggested since many ALS-related proteins such as vesicle 
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associated membrane protein (VABP) and Alsin 2 (ALS2) are involved in 
vesicular transport. The downregulation of the glutamate transporter 
EAAT, responsible for removal of excess glutamate from the synaptic cleft 
leading to excitotoxicity, is an obvious and deeply researched mechanism 
(Shaw & Eggett, 2000). Neuroinflammation as a result of activation of 
astrocytes and microglial with oligodendrocytes dysfunction may be a 
contributing mechanism (Van damme et al., 2017).  
Of the several proposed mechanisms of ALS progression, which include 
RNA metabolism, mitochondrial function impairment, endocytic 
impairment, oxidative stress, problems with misfolded proteins and 
autophagy, glutamate signalling and excitotoxicity, (Alami et al., 2014; 
Bowling et al., 1993; Hirano et al., 1984; Kawahara et al., 2004; Niwa et 
al., 2002; Prasad et al., 2019; Swerdlow et al., 1998; Takuma et al., 1999; 
Wiedemann et al., 2002; Zhang et al., 2018), only the axonal transport 
irregularities underline the important contribution of  microtubules and the 
cytoskeleton in the neurodegenerative process while also taking into 
account the intracellular transport (Cueille et al., 2007; Robberecht & 
Philips, 2013).   
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Figure 4 Schematic representation of proposed mechanisms of ALS disease. (1) Alterations in 
nucleocytoplasmic transport of RNA molecules and RNA-binding proteins. (2) Altered RNA metabolism: 
several important RNA-binding proteins become mis-localized in ALS, with cytosolic accumulation and 
nuclear depletion which causes defects in transcription and splicing. Altered dynamics of stress granule 
formation or disassembly can propagate cytoplasmic aggregate formation. (3) Impaired proteostasis 
with accumulation of aggregating proteins  causing overload of the proteasome system and reduced 
autophagy may contribute and/or cause this accumulation. (4) Impaired DNA repair could also 
contribute to ALS pathogenesis. (5) Mitochondrial dysfunction and oxidative stress: many ALS-related 
proteins can enter mitochondria and disrupt normal functioning causing increased formation of reactive 
oxygen species (ROS). (6) Oligodendrocyte dysfunction and degeneration, leading to reduced support 
for motor neurons. (7) Neuroinflammation: activated astrocytes and microglia secrete fewer 
neuroprotective factors and more toxic factors. (8) Defective axonal transport: many ALS-related 
mutations cause disorganization of the cytoskeletal proteins and disrupt axonal transport. (9) Defective 
vesicular transport: Many ALS-related proteins are involved in vesicular transport, suggesting that 
impaired vesicular transport contributes to ALS pathogenesis. (10) Excitotoxicity: loss of the astroglia 
glutamate transporter EAAT2 causes accumulation of extracellular glutamate, which causes excessive 





1.1.5 Models of Amyotrophic Lateral Sclerosis  
Several models have been developed based on molecular and genetic 
analysis of ALS to study specific aspects of the disease because a single 
model cannot recapitulate the exact human disease with its multifactorial 
and multidimensional features. They vary from cell culture systems to 
Drosophila, to rodents and recently human patient-derived stem cell 
models (Van Damme et al., 2017) (Figure 5). Each model presents 
peculiar merits and demerits all of which contribute to our understanding 
of the disease (Figure 5). Most probably, a combination of the systems 
will allow us achieve a successful translation from laboratories to the 




Figure 5 Models currently in use for research in ALS. Merits and demerits of each system is 
summarized from yeast to IPSC-derived neurons. Adapted from (Van Damme et al., 2017). 
  
Many cell lines are used to test and screen the biological functions of ALS-
associated genes and proteins. Even if such simple models cannot 
recapitulate the complex human disease, they do contribute significantly 
to the understanding of the pathology of the disease. One of such models 
uncovered the role of C9orf72 in autophagy (Webster et al., 2016). The 
discovery of  RNA-binding protein ATAXIN 2 (ATXN2) as a genetic risk 
factor for ALS resulted from analysis performed on a single cell organism 
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like yeast (Saccharomyces cerevisiae), also for the identification of 
molecules modifier of TDP-43.  
Yeast, that present about 30% homology between its genes and that of 
humans, is a quite suitable organism for cytotoxic screening since a 
simple growth assay could indicate toxicity manifested as reduced growth 
rate (Elden et al., 2010; Jovičič et al., 2015). Primary cultures of motor 
neurons of mice and rats are useful to study the exposure and vulnerability 
of motor neurons to various factors and insults. They are also useful in 
understanding the factors that improve their survival in unbiased screens 
in an effort to study the cellular effects of gene mutations and protein 
aggregations (Bordet et al., 2007; Van Damme et al., 2017). 
Coming to multicellular organisms, C. elegans (Caenorhabditis elegans) 
is a transparent nematode with about 35% gene homology with humans 
has contributed significantly to ALS research. The four main ALS-
associated genes (SOD1, C9orf72, TARDBP and FUS) have been 
created in this model system (Therrien & Parker, 2014). A TDP-43 
proteinopathy model using C. elegans revealed Calcineurin as an 
important phosphatase that is involved in the removal of pathological C-
terminal phosphorylation of TDP-43 (Liachko et al., 2016).   
Zebrafish (Danio rerio) with approximately 90% gene homology with 
humans is famous in embryology research for its transparent embryos and 
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is gaining tract as a model in ALS study (Phillips & Westerfield, 2014). 
There are Zebra fish models of ALS in which interactions and similarities 
in TDP-43 and FUS proteins related to motor neuron toxicity have been 
discovered. With this model, it was discovered that the expression of the 
wild-type genes of TDP-43 and FUS could rescue the motor neuron 
toxicity induced by the knockdown of their respective genes, but not the 
toxicity induced by a mutant SOD1 expression (Kabashi et al., 2011). 
Additionally, progranulin, a neurotrophic factor was found to improve the 
motor neuron toxicity induced by mutant TDP-43 and FUS, but not of 
mutant SOD1 (Kabashi et al., 2011; Laird et al., 2010). 
Drosophila melanogaster, the fruit fly, with a 75% gene homology with 
humans is the most common small animal model in ALS research for 
several good reasons such as an array of genetic tools available for 
various screenings and manipulations (Ugur et al., 2016). There are 
numerous fly models of ALS linked to mutations in SOD1 (Watson et al., 
2008), in TARDBP (Estes et al., 2011; Feiguin et al., 2009; Vanden Broeck 
et al., 2013) in FUS (Lanson et al., 2011), in C9orf72 (Mizielinska et al., 
2014; Xu et al., 2013), in ALS2 (Takayama et al., 2014), in VAPB 
(Ratnaparkhi et al.,  2008; Tsuda et al., 2008), in VCP (Johnson et al., 
2015) and in SETX (Mushtaq et al., 2016). Several validation and 
confirmation experiments have been carried out using the fly, such as the 
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role of stress granule factors poly-(A)-binding protein (PABP) and eIF2a 
phosphorylation as modifiers of TDP-43 toxicity (Kim et al., 2014). The 
Drosophila model of ALS shed more light on the physiological role of TDP-
43 with respect to its interactions with synaptic proteins such as Syntaxin, 
Synapsin and CSP (Romano et al., 2014) and the control of the growth of 
the neuromuscular junction by mediating the action of the microtubule 
binding protein, Futsch (Godena et al., 2011) (Figure 22).  
Rodent models with >90% gene homology with humans are the most 
desirable in modelling human diseases. Gurney et al., 1994 provided the 
first transgenic mice overexpressing the human genomic mutant SOD1. 
Since then, several other rodent models involving many of the ALS-
associated proteins have been generated, all of which have contributed 
significantly to our understanding of the disease pathogenesis. This 
includes uncovering links between protein misfolding and aggregation, 
autophagy, vesicular and axonal transport, mitochondrial dysfunction and 
cytoskeletal alterations (Fischer et al., 2004; Shi et al., 2010; Staats et al., 
2013) Although, the mammalian rodent systems are similar to the humans 
and offer great advantages providing good insights into the disease, they 
possess peculiar problems such as inbreeding which may become 
unreliable when crossbreeding with another transgenic line is required. 
This does not model the exact human condition and restrict the testing of 
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hypotheses to one at a time eventually becoming extremely expensive 
and time-consuming (Van Damme et al., 2017).  
Patient induced stem cell models are a boost to ALS research as they 
obliterate the requirement of overexpressing a particular pathogenic 
transgene associated with ALS since they already contain an endogenous 
mutation with respect to the patient’s own genetic makeup, thus they are 
a better model for ALS (Van Damme et al., 2017). Many aspects of the 
disease such as protein aggregation/mis-localization and functional read-
outs like neuro-filamentous disorganization, inefficient nucleocytoplasmic 
transport, increased motor neuron death and excitotoxicity have been 
modelled successfully using iPSC-derived spinal neurons (Bilican et al., 
2012; Chen et al., 2014; Kiskinis et al., 2018; Matus et al., 2014; Zhang et 
al., 2015). There is hope that future use of gene editing techniques such 
as CRISPR/CAS9 for genetic screens in patient-derived stem cells 
phenotypic read-outs can possibly be more successful in ALS direct 
translational research since they already have the genetic background of 
an individual that is afflicted with ALS (Qi et al., 2017).  
     1.2  Transactive response DNA binding protein 43 kDa (TDP-
43)   
The 43kDa RNA-binding protein, TDP- 43 contains 414 amino acids. It is 
central to ALS pathophysiology because its mis-localization from the 
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nucleus where it is predominantly located to the cytoplasm in the form of 
insoluble ubiquitinated aggregates is found in most patients. The 
presence of these aggregates is considered one of the hallmarks of the 
disease (Barber et al., 2006; Coyne et al., 2014; Neumann et al., 2006; 
Saberi et al., 2015). Dominant mutations of this protein are enough to 
cause the familial ALS reiterating the unrivalled role of TDP-43 in the 
pathogenesis of the disease (Al-Chalabi et al., 2012). Together with ALS, 
Frontotemporal lobal degeneration, Primary lateral sclerosis and 
Progressive muscular dystrophy are collectively known as TDP-43 
proteinopathies. They are all related with mutations and aggregation of 
this protein (Dugger & Dickson, 2017). Only TDP-43 associated with ALS 
is within the scope of this study.   
TDP-43 encoded by the TARDP gene located on chromosome 1 has an 
N-terminal domain which contains 2 RNA recognition motifs for binding 
RNAs and DNAs, a nuclear localization and export signals for presence 
in the nucleus and shuttling to the cytoplasm respectively, a C-terminal 
domain that contains a Q/N (glutamine/asparagine)  and a glycine-rich 
regions (Figure 6). It also contains mitochondrial localization motifs M1, 
M3, and M5. (Prasad et al., 2019). There is considerable overlap in TDP-





Figure 6 Schematic representation of TDP-43 structure comprising an NT domain, two RRM 
domains, a nuclear export signal (NES), a nuclear localization signal (NLS), a prionlike disordered C-
terminal domain (with glutamine/asparagine-rich (Q/N) and Glycine-rich regions) and mitochondrial 
localization motifs (M1−35–41; M3−146–150; M5−294–300). Figure adapted from (Prasad et al., 2019).  
 
1.2.1 Functions of TDP-43  
TDP-43 function is vital to the development of mammals, zebra fish and 
invertebrates (Diaper et al., 2013; Estes et al., 2011; Feiguin et al., 2009; 
Kabashi et al., 2009; Kraemer et al., 2010; Rowland & Shneider, 2001; 
Yang et al., 2014; Zhang et al., 2003). Its role includes, but is not limited 
to splicing, mRNA stability, transport, and translation. Also, microRNA 
biogenesis and long non-coding RNA (lncRNA) processing. All of these 
processes are related to RNA metabolism (Buratti & Baralle, 2009; 






Figure 7 Schematic representation of TDP-43 functions. It is a constitutively expressed protein that 
is involved in many processes and exerts its function through mediation of other proteins, RNAs and 
recently discovered miRNAs. Figure adapted from (Prasad et al., 2019). 
 
mRNA transcription and splicing.   
TDP-43 localizes to the euchromatin regions of the nucleus where 
transcription and splicing occur in the physiological state. It is involved in 
the regulation of transcripts of several genes such as CFTR, FUS and of 
itself, TARDP gene, among others (Buratti & Baralle, 2010). Alterations in 
the presence or absence of TDP-43 is detrimental. Nuclear depletion 
causes splicing aberrations also in the motor neurons. While 
overexpression leads to the formation of complexes that makes it 





mRNA Maturation and Stability  
TDP-43 binds to the transcripts of many mRNAs including its own through 
their 3′-untranslated regions (3′-UTR) altering their half-lives and 
consequently stabilizing them. Its own transcript, the human low molecular 
weight neurofilament mRNA and the vascular endothelial growth factor 
are classical examples (Prasad et al., 2019).  
mRNA Translation  
TDP-43 was reported to bind more than 6000 RNA sequences by a  high 
throughput sequencing of CLIP RNA derivatives which give credence to 
the importance of this protein to viability (Tollervey et al., 2011).  It can 
negatively affect the translation of many mRNAs by seclusion of factors 
involved in translation into stress granules (Aulas et al., 2015). TDP-43 
regulates the translation of Futsch which is the Drosophila homologue of 
the mammalian MAP1B at the neuromuscular junctions (Coyne et al., 
2014).  
mRNA Transport  
mRNAs are transported to far locations by ribonucleoprotein (RNP) 
granules on microtubules in some instances. TDP-43 interacts with RNAs 
to produce these RNPs whose transportation has been found to be 
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negatively affected in an ALS-associated TDP-43 mutation (Alami et al., 
2014).  
miRNA and lncRNAs Processing  
TDP-43 is involved in the biogenesis, maturation and processing of micro 
RNAs (miRNAs) and long non-coding RNAs (lncRNAs). This is through 
interactions with drosha and dicer complexes (Buratti & Baralle, 2010). 
Nuclear enriched abundant transcript 1 (NEAT1) and Metastasis 
associated in lung adenocarcinoma transcript 1 (MALAT1) are lncRNAs 
that bind with TDP-43 and are also found at elevated levels in FTLD of 
TDP-43 origin (Tollervey et al., 2011). Although lncRNAs (>200 
nucleotides) do not encode for proteins, they are believed to be involved 
in various mechanisms associated with regulation of gene expression 
(Prasad et al., 2019).  
 Stress Granule Formation  
Stress granules are formed quickly and usually in a reversible manner 
upon exposure to conditions such as oxidative stress, infections among 
others (Anderson & Kedersha, 2008). So, formation of stress granules are 
a protective reaction in the cell upon exposure to insults and injury. They 
can become pathological inclusion bodies as seen in the brains of ALS 
and FTLD patients (Van Damme et al., 2008). TDP-43 is involved in the 
assembly and maintenance of stress granules. It regulates the expression 
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of  rasGAP SH3 domain binding protein 1 (G3BP) and T cell-restricted 
intracellular antigen-1 (TIA-1) which are key stress granule nucleating 
proteins (McDonald et al., 2011).  
TDP-43 regulates itself by binding to the 3′ untranslated region (UTR) of 
its own mRNA transcript thereby keeping its cellular level, and possibly 
solubility constant, an action it also performs for several other transcripts 
which is the basis for its mRNA regulatory function (Ayala et al., 2011). A 
change in this level either by increase (overexpression leading to a gain 
of function) or decrease, associated with a loss of function, is the rationale 
of several animal model studies recapitulating many aspects of ALS 
phenotype and pathology such as reduced lifespan, locomotion defects, 
uncoordinated movements and progressive neurodegeneration leading to 
paralysis (Chiang et al., 2010).  
One of such models was generated and in use in our laboratory where 
Drosophila that lacks TBPH (by gene deletion), the fly homologue of 
human TDP-43, recapitulate phenotypes of ALS (Feiguin et al., 2009). 
Moreover, in null alleles of TBPH, alterations in the organization of the 
synaptic microtubules in the terminal boutons of the neuromuscular 
junctions were observed, due to the fact that TBPH mediates the Futsch 
function, a microtubule associated protein (Feiguin et al., 2009; Godena 
et al., 2011).   
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1.3 Microtubules and their associated proteins  
Microtubules are hollow polymers of alpha and beta tubulin dimers. The 
dimers are arranged to form a polarized structure having plus (beta 
tubulin) and minus (alpha tubulin) ends. Their general functions in different 
animals and cell types are conserved as regards motility and cell division 
(Clark et al., 2016) (Figure 8). They are an important component of the 
neuronal cytoskeleton and play a key role in the development, growth and 
maintenance of neuronal functions (De Vos & Hafezparast, 2017). They 
provide the structural framework for distinct axonal and dendritic 
compartments and many neurodegenerative diseases are characterized 
by changes in specific cytoskeletal components (Brandt, 2001; McMurray, 
2000).  Neuronal microtubules play an essential role in the transport and 
subsequent regulation of synaptic vesicle dynamics underlying 
neurotransmission (Rodesch & Broadie, 2000). They are also important 
in facilitating activity-dependent axonal transport of varying structures 
(Clark et al., 2016).  The dynamic nature of microtubules and the strict 
regulation of their stability allow them perform their dynamic functions in 
all cell types (Brunden et al., 2017). They are constantly required to be in 
a state of dynamic instability, an energy-intensive process where they are 
able to switch between a growing state, which requires addition of 
subunits to their end (assembly), and a shortening state, where 
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protofilaments are able to break off to release single units of dimers into 
the cytoplasm (disassembly) (Cassimeris, 2010).   
Neuronal polarity is conferred by microtubules by virtue of the slow-
growing minus end composed of alpha tubulin and a fast-growing plus end 
with beta tubulin forming different neuronal compartments. The axonal 
compartment is entirely composed of microtubules oriented with their plus 
end distally located while the somato-dendritic  compartment contains an 
equal amount of plus and minus ends microtubules distally implying a 
mixed orientation (Yau et al., 2016). Although yet to be fully understood, 
numerous post translational modifications of tubulin such as acetylation, 
tyrosination, glutamylation, polyamination, glycylation and 
glutathyonilation are chemical modifications sought as potential 
therapeutic targets for neurodegenerative disorders. They are thought to 
aid the functions of microtubules by improving stability and affecting 
specific binding domains of their associated proteins (Taes et al., 2013).  
Microtubule associated proteins (MAPs) are a large group of  ‘structural’ 
proteins that have the ability to interact with the microtubule assembly 
promoting their instability or stability. This is achieved by cutting 
microtubules or preventing them from depolymerization respectively 
(Cassimeris, 2010; De Vos & Hafezparast, 2017). MAPs improve the 
functions of microtubules by facilitating intracellular signalling, 
62 
 
cytoskeletal interactions and altering microtubule stability and dynamics 
(Sayas et al., 2015). The classical MAPs expressed only in neurons are 
MAP1a and 1b, MAP2 and tau, of which the last two are the most 
characterized (De Vos & Hafezparast, 2017; Halpain & Dehmelt, 2006; 
Villarroel-Campos & Gonzalez-Billault, 2014). This study will focus on 
Futsch, the Drosophila orthologue of the MAP1B.     
 
                    
Figure 8 Schematic structure of a microtubule: Typically contains about 13 protofilaments in parallel 
binding in a head-tail fashion and the external and internal dimensions are about 24nm and 12nm 
respectively. MAPs can be stabilizing, destabilizing or severing proteins depending on their actions on 
microtubules inferable from their names.  
 
MAPs bind to microtubules to influence their structure and behaviour 
which invariably control their functions (Figure 9). Some MAPs prevent 
bundling of microtubules by keeping them apart (Figure 9A), others control 
the numbers of microtubule protofilaments through their connections to 
specific number of tubulin molecules (Figure 9E). Most MAPs act as 
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cellular crosslinkers between microtubules and the filaments (actin and 
intermediate filaments) (Figure 9D) while others guard against breaking of 
the microtubules influencing their dynamics (Figure 9C). Some MAPs 
have been implicated in intracellular transport (Figure 9F) while a few 
others are thought to have roles in neuronal membrane trafficking  (Figure 
9B) (Bodakuntla et al., 2019). 
 
Figure 9 : Schematic representation of ways MAPs bind to microtubules to influence their 
functions: (A) binding and spacing microtubules with long MAP projection domains, (B) connecting 
microtubules to membranes, (C) protecting microtubules from cutting enzymes thus, preventing 
disassembly, (D) crosslinking different cytoskeletal elements, (E) controlling the protofilament numbers 
of microtubules, (F) affecting the binding and motility of motor proteins by either forming a complex with 
the motor, or by occupying the motor path at the microtubule surface, (G) promoting microtubule 




Alterations in microtubule-associated proteins (MAPs) are associated with  
several congenital and sporadic age-related neurological disorders such 
as tauopathies, characterized by filamentous inclusions of 
hyperphosphorylated Tau (Johnson & Bailey, 2002). Mutated Tau in FTLD 
with parkinsonism linked to chromosome 17 (Spillantini & Goedert, 1998) 
presents neurofibrillary tangles and neurodegeneration caused by an 
abnormal increase in the number of microtubule binding domains in Tau. 
(Hutton et al., 1998). Although, the classical MAPs differ in their structures 
and major functions, they all bind to tubulin, stabilize microtubules and are 
able to connect to other components of the cytoskeleton such as actin 
thus, there is a functional redundancy in the MAPs (da Cruz, 2005).  
MAP1B is crucial to the formation and maintenance of a functional 
nervous system as suggested by the embryonic lethality recorded in its 
hypomorphic murine mutant (Gonzalez-Billault et al., 2001). Takei et al., 
1997) reported a noticeable delay in the development of the nervous 
system in a MAP1B mutant in which the first 571 amino acids were 
preserved. MAP1B is localized to areas rich in “unstable” microtubules 
such as dendritic spines and axonal growth cones where it has an 
important function in mediating their dynamics through direct physical 
interactions and probably signalling (Ketschek et al., 2015; Tortosa et al., 
2013; Tymanskyj et al., 2012; Villarroel-Campos & Gonzalez-Billault, 
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2014). It has also been implicated in membrane trafficking in neurons 
through its regulatory action on Rab35, a protein involved in vesicle 
recycling. (Villarroel-Campos et al., 2016).  
1.4 Microtubules in Amyotrophic Lateral Sclerosis (ALS)  
Mutations in microtubule proteins, as precise cause of ALS and other 
neurodegenerative disorders, are yet to be defined as either direct or 
indirect effect (Clark et al., 2016), but problems involving microtubules and 
their associated proteins have been linked to several neurodegenerative 
diseases such as Amyotrophic Lateral Sclerosis (ALS, (Smith et al., 
2014), Parkinson’s disease (PD, (Cartelli et al., 2010), Alzheimer’s 
disease (AD, (Matsuyama & Jarvik, 1989), Schizophrenia (Andrieux et al., 
2006), Huntington’s disease (HD) and various congenital developmental 
disorders (Tischfield & Engle, 2010). Recent literature suggests that the 
disruption of microtubule stability and its dynamics, possibly as a result of 
alterations in their associated proteins, may be the initial propeller behind 
several sporadic and familial ALS disease. This presupposes that 
microtubule-mediated deficits in axonal transport are the threshold point 
for motor neuron viability (Clark et al., 2016). Mutations in TUBA4A, a 
microtubule protein of tubulin isoform is sufficient to cause a very rare form 




     
 
Figure 10 Modifications to neuronal microtubules (MT) in amyotrophic lateral sclerosis (ALS). 
(A) Normal microtubule +TIP dynamics and kinesin/dynein transport, mRNA granule transport and 
chemical modifications. (B) Mutant superoxide dismutase 1 (SOD1) expression leading to microtubule 
hyperdynamics, increased +TIP protein density, decreased transport, increased acetylation, 
phosphorylation of microtubule associated proteins (MAPs) and accumulation of microtubule protein 
containing aggregates. (C) Mutant TDP-43 expression causes dysfunction in mRNA granule transport. 
Decreased local translation of MAP1B mRNA is also observed in TDP-43 mutants. (D) Mutant TUBA4A 
expression alters microtubule dynamics and network stability, with unknown impact on +TIP proteins, 
transport or chemical modifications. Select mutations are incorporated into intracellular aggregates. (E) 
Energy depletion and calcium dysregulation generates increased microtubule depolymerization, tubulin 
guanosine triphosphate (GTP) cap hydrolysis, and increased MAP phosphorylation. (F) Neuronal 
oxidative stress leads to tubulin glutathionylation, increased microtubule depolymerization, decreased 
axonal transport and alterations to MAPs, with unknown impact on classical chemical modifications or 
+TIP proteins. (adapted from Clark et al., 2016. Figure inclusive).  
 
TDP-43 is involved in mRNA transport through interactions with the 
microtubule-dependent transport of mRNP granules (Alami et al., 2014). 
This is of significance because TDP-43 is involved in mRNA translation of 
proteins locally, especially at the neuromuscular junction and other 
synapses, which suggests that alteration in this transport event is 
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implicated in the reduction of important proteins necessary for axonal and 
synaptic growth. (Fallini et al., 2012; Lagier-Tourenne et al., 2012; 
Polymenidou et al., 2011) (Figure 10C).  
SOD1 mutations account for approximately 20% of all familial ALS cases 
(Robberecht and Philips, 2013) and several mice models are available. 
These mice were found to have significant alterations in axonal transport 
which presuppose a connection with the microtubules and indeed change 
in their dynamics have been reported to be causal for the motor neuron 
malfunctions seen in these mice (Kleele et al., 2014) (Figure 10B). A 
mutation that occurs more frequently than other previously known 
mutations in FTLD and both sALS and fALS called the hexanucleotide 
repeat expansion of the non-coding region of open reading frame 72 on 
chromosome 9 (C9ORF72) was identified in 2009 (DeJesus-Hernandez 
et al., 2011; Renton et al., 2011). Although, the mechanism of its 
pathogenesis is still obscure, a link with the microtubules has been 
suggested based on the homology of the C9ORF72 to a guanine 
nucleotide exchange factor (GEF) which is a signalling factor for the Rab-
GTPases involved in vesicular trafficking of proteins (Droppelmann et al., 
2014).   
Brockington et al., 2010 reported a decreased expression of the 
microtubule associated proteins Tau, MAP1B, and MAP6 in a vascular 
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endothelial growth factor (VEGF) mice model of ALS predicting a possible 
dysfunction in the stability of microtubules in ALS. (Park et al., 2013) 
reported a cause for microtubule depolymerization as a result of energy 
depletion which in a vicious cycle subsequently promote the inability of 
the microtubules to facilitate movement of mitochondria (Figure 10). This 
leads to an accumulation of these organelles as observed in SOD1 mutant 
mice (Park et al., 2013). Inhibition of kinesin bindings on microtubules has 
been suggested as part of the toxic mechanism in ALS.  
Excitotoxicity leading to motor neuron death which can be by excessive 
intracellular calcium levels, overstimulation by glutamate, damaged 
mitochondria or lack of calcium ion buffers has been reported to be a 
primary mechanism in ALS (Blizzard et al., 2015). Direct alteration of 
microtubule dynamics by calcium is possible  (Figure 10E) (O’Brien et al., 
1997) and increased levels of calcium can cause depolymerization of 
microtubules containing MAPs causing destabilization which can lead to 
caspase activation and subsequent collapse of the cytoskeleton (King et 
al., 2014). Also, abnormal activity of cyclin dependent kinase 5 (CDK5) 
which is reported in the SOD1 mouse model of ALS can be caused by 
excessive intracellular calcium levels (Patzke & Tsai, 2002). Damaged 
mitochondria producing excessive and aberrant reactive oxygen species 
increase the oxidative stress environment which can lead to the oxidation 
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of tubulin and some microtubule associated proteins thus having a 
destabilization effect on the microtubules. Glutathionylation of tubulin also 
occur particularly in the motor neurons changing the structure of 
microtubules and their dynamics (Carletti et al., 2011) (Figure 10F).  
1.5 Mitochondria Dysfunction in Amyotrophic Lateral Sclerosis   
Mitochondria, often referred to as the ‘power house’ of a cell, are double 
membrane-bound organelles involved in several important processes 
necessary for survival of the cell. Such processes include ATP and 
reactive oxygen species (ROS) generation, synthesis of metabolites and 
calcium homeostasis (Benard et al., 2007). Motor neurons with very long 
axons and dendrites possess limited glycolytic abilities. They rely mostly 
on mitochondria to provide energy required for the maintenance of 
synaptic transmission and activities in the ion channels. Thus, 
mitochondria are needed to be efficiently transported to regions of high 
energy demands such as the neuromuscular junctions (Sheng, 2014) 
(Figure 11).  
It is perhaps pertinent to recall and note, that the first mutation identified 
in association with fALS, is the one of  the SOD1 gene that is localized to 
the mitochondria and is involved in the regulation of its functions. This 
presupposes a role for mitochondrial dysfunction in the biogenesis of the 
disease (Deng et al., 2006; Israelson et al., 2010; Kawamata & Manfredi, 
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2010). Reduced respiration rate and ATP synthesis are symptoms of 
mitochondria dysfunction observed in ALS patients, symptoms that 
precede rather than follow behavioural deficits (Mattiazzi et al., 2002). 
Similarly, experimental models of ALS both in vitro and in vivo have 
recorded impaired activities of oxidative phosphorylation (OXPHOS) 
complexes, elevated mitochondria calcium levels and increased 
production of reactive oxygen species leading to loss of anti-oxidant 
activities. These were also recorded as increase oxidative stress in the 
spinal cords of ALS patients (Ikawa et al., 2015; Wiedemann et al., 2002).   
TDP-43, an important protein in ALS pathogenesis, that can localize to 
the mitochondria, has been found to be accumulated in the mitochondria 
of subjects with ALS and FTLD activating its unfolded protein response 
and thereby causing damage (Wang et al., 2019). The inhibition of TDP-
43 mitochondria localization blocks its neuronal toxicity, linking 
mitochondria bioenergetics to TDP-43 neuronal toxicity (Wang et al., 
2016). Also, there is evidence that TDP-43 interacts with key mitochondria 
proteins such as voltage-gated anion channel 1 (VDAC1),  Prohibitin 2 
(PHB2), a crucial mitophagy receptor and mitochondria protease LonP1 
(Davis et al., 2018; Wang et al., 2019) implicating mitochondria 





   
Figure 11 Schematic showing several aspects of mitochondria functions affected in ALS. (A) 
Normal mitochondrial functions in the physiologic state with a balanced dynamic of fission/fusion 
reactions, efficient trafficking as required in different compartments and regulated bioenergetics. (B) 
Impaired mitochondrial functioning in ALS with fragmentation, altered bioenergetics causing increase 
production of ROS, reduced ATP and inefficient transport (figure adapted from www.researchgate.net).  
 
Abnormal mitochondria morphology or fragmentation has also been 
reported in TDP-43 associated models in mice, cell lines and biopsied 
human spinal cords tissues (Hirano et al., 1984; Magrané et al.,  2014; 
Song et al., 2013; Velde et al., 2011; Vinsant et al., 2013). This possibly 
results from more fission than fusion of the mitochondria that are 
constantly required to be in a dynamic state of fission/fusion (McBride et 
al., 2006; Wang et al., 2013). Mitochondria fusion and fission proteins 
have been implicated directly in mitochondria bioenergetics as they 
regulate respiratory complex assemblies and are vital to the maintenance 
of mitochondria functions (Cogliati et al., 2013; Liu et al., 2012) So, 
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alterations in mitochondria structural dynamics possibly have a 
contributory role in the mechanism of ALS pathogenesis (Jiang et al., 
2015).  
Altered mitochondria distribution is becoming recognized as an important 
factor contributing to many neurodegenerative diseases not only to ALS. 
Mitochondria are distributed in different compartments of the neurons 
according to their energy demands so that, areas around synapses with 
great energy requirements have more mitochondria than other regions 
with less energy requirements (Jiang et al., 2015). Significant 
mitochondria clusters in the soma and proximal axonal hillock have been 
reported in the lumbar spinal cords of ALS patients and  similarly in the 
motor neurons of SOD1 and TDP-43 cell and animal models (De vos et 
al., 2007; Igaz et al., 2011; Janssens et al., 2013; Sasaki & Iwata, 2007; 
Sotelo-Silveira et al., 2009). This implies that efficient trafficking of 
mitochondria is extremely important in order to successfully fulfil all energy 
requirements of the neuron to maintain its functions (Figure 11).  
Newly formed mitochondria must be able to move to the synapses and 
dendrites where they are required and conversely, damaged mitochondria 
must also be able to move back to the soma for degradation. So, 
movement of mitochondria is bidirectional utilizing both retrograde and 
anterograde transport which are respectively regulated by dynein and 
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kinesin motor proteins (Sasaki & Iwata, 2007; Schwarz, 2013). 
Microtubules are the highway for fast transport while actin filaments are 
the ones used for slow movement (Frederick & Shaw, 2007). The role of 
mitochondria dynamics in the pathogenesis of neurodegenerative 
diseases is becoming more pronounced though the exact mechanism of 
progression is still obscure and thus, is a viable research path worth 
pursuing. It is definitely a common pathology that could be insightful (Jiang 
et al., 2015).   
    1.6 Drosophila melanogaster  
D. melanogaster is a Dipteran commonly known as the fruit fly. Thomas 
Morgan and his colleagues are known as the pioneers of using the fly for 
biological research since the 1900s. This small but useful invertebrate 
model has proven to be a good one for studying neurodegeneration since 
1972 when Hotta and Benzer identified the first neurodegenerative 
mutant, dropdead, in a fly phototaxis gene screen (Zhang et al., 2018). 
The fly is particularly favoured over other animal models because it is 
easier, faster and cheaper to maintain. It has a short life span of about 50 
days. It has approximately 14000 genes distributed on 4 chromosomes 
and 75% of human genes has a functional fly orthologue with a general 
40% homology (McGurk et al., 2015).  
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1.6.1 Life cycle of Drosophila  
At 25 degrees Celsius, the life cycle of Drosophila is completed in about 
10-14 days (Figure 12), and being temperature sensitive, at higher 
temperature, the cycle shortens while it slightly lengthens at lower ones. 
Egg laying marks the beginning of embryogenesis and is completed in 
about 22 hours. Development into first instar larva occurs approximately 
24 hours after egg laying (AEL) and is followed respectively by the second 
and third instar larva 48 and 72 hours after AEL. The larva becomes pupa 
in about 2-3 days and metamorphosis is completed when the adult fly 
eclose from the pupa case, a process that takes about 4-5days (Figure 
12). Newly born flies are distinct for their light body pigmentation and 











       
Figure 12 Life cycle of D. melanogaster. The cycle is completed in 10-14 days at 25degrees Celsius 
and  sexual maturity is attained by 4-8hours after Eclosion. Young female flies can lay up to 100 eggs 
in a day and virgin females lay few sterile eggs (figure adapted from www.researchgate.net).  
 
Drosophila are sexually dimorphic with males and females looking 
different yet similar (Figure 13). The males have a pair of sex combs on 
the forelegs  and a black pair of claspers at the tip of the abdomen. The 
females, generally bigger, become sexually active about 8 hours after 





          
Figure 13 Illustrations of male and female D. melanogaster. Females are slightly bigger than the 
males with seven abdominal segments while the males have five. They are visibly distinguishable by 
the tip of their abdomen. It is light and pointed in the females while it is dark and round in the males.  
(figure adapted from www.carlsonstockart.com).  
 
    1.6.2 Modelling Human Diseases in Drosophila  
The fly brain is quite complex, yet it is simpler than the mammalian 
counterpart. It is able to handle high-tasking motor functions such as 
climbing, flying and walking. It consists of about 100,000 neurons as 
compared with the more than a billion present in the human brain (Pandey 
& Nichols, 2011). Importantly, a wide range of tools and methods including 
the famous UAS/GAL4 system (Brand & Perrimon, 1993) are available for 
genetic manipulations and various studies of human diseases (Ugur et al., 
2016).    
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While the fly embryo is particularly favoured in developmental studies 
such as organogenesis, cell fate patterning and determination, and 
neuronal development, the third instar larva is mostly used to study 
physiological processes since innate tasks like crawling, can provide 
important phenotypic insights. Significant contributions has been made to 
the study of human biology by the examination of  certain molecular and 
genetic mechanisms of the developmental processes in the pupa using 
the imaginal discs which are composed of undifferentiated cells that will 
eventually form all the adult structures. The adult fly, although significantly 
different from humans has an appreciable degree of conserved biology. It 
possesses a brain that can mediate complex behaviours such as learning 
and memory, sleep, aggression, circadian rhythm, courtship, walking and 
climbing among others. So, the adult fly is used to study quite a wide range 
of processes genetically including neurodegeneration (Pandey and 
Nichols, 2011).  
Forward genetics approach involves expressing in flies, human genes 
with specific mutations linked with the disease in question and screening 
in vivo the function of these proteins. While reverse genetics involves 
studying the function of the conserved gene of endogenous proteins with 
the strongest homology linked with the human disease in the fly. Both 
approaches are used to study the molecular function of human genes in 
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Drosophila employing the UAS/GAL4 system (Galactose-4, upstream 
activating sequence). This allows the possibility of having different 
phenotypes by increasing, decreasing or eliminating gene expression in a 
tissue specific manner (Brand and Perrimon, 1993). Numerous 
neurodegenerative disease models in flies have been created using this 
system. With the UAS/GAl4 system it is possible to allow the expression 
of any transgene in a tissue-specific manner. Any gene, also a human 
disease-linked transgene, can be cloned downstream of UAS sequences, 
to which GAL-4, a yeast transcriptional activator, specifically binds to 
activate gene transcription. The GAL-4 gene is generally fused to a 
selected promoter, tissue specific, so that only when the fly harbouring the 
GAL-4  is crossed with the one harbouring the UAS fused to the gene of 
interest, is the gene expressed thanks to the transcriptional activity of 
GAL-4 in a tissue specific manner in the progeny of the flies crossed 









               
Figure 14 UAS/GAL-4 system. In a fly line, a transgene is placed downstream a UAS activation domain 
containing the binding sites of GAL-4 and in another fly line, GAL-4 is placed with a tissue specific 
enhancer. This allows the expression of the said gene in the the specific tissue of the offspring. Figure 
adapted from (Kelly et al., 2017). 
 
Genome wide screening to identify possible influencers can be performed 
once the fly model of neurodegenerative disease reproduces specific 
phenotypes linked with the disease. Hypomorphic alleles can also be 
created using the UAS/GAL4 system by inducing the expression of 
interference RNAs, known as RNAi, cloned under UAS control, against 
specific genes (Figure 14). Large screening of mutations of genes that 
affect a neurodegenerative phenotype is also another way of searching 
for possible modifiers of a disease with an unbiased approach that can 
lead to the discovery and identification of new pathways and proteins 
involved in the disease mechanism (Muqit & Feany, 2002).   
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1.6.3 Drosophila Neuromuscular Junction   
The neuromuscular junction of the fly larva is an excellent model to study 
synaptic development, organization, function and transmission. This is 
because it is large, easily seen, singularly specified and the whole system 
is relatively simple (Keshishian, 1996). It is similar to human synaptic 
plaques and central glutamatergic synapses in the brain. It can also be 
easily manipulated both anatomically and physiologically (Menon et al., 
2013). It is a model of choice as many of the proteins involved in synapses 
are conserved in Drosophila and vertebrates so, their development at the 
molecular and cellular level are very similar (Keshishian, 1996) (Figure 
15C).  
                                 
Figure 15 Schematic representation of (A) Abdominal segments A2-A6 of a dissected third instar 
larva showing the NMJ. (B) Innervation of one abdominal hemi-segments  shown in (C)The NMJ of the 
6 and 7 muscles of the same segment showing the nerves. Larvae are bilaterally symmetrical from 
abdominal segment 2-7. Figure adapted from (Pérez-Moreno & O’Kane, 2018). 
                             
C     
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There are 30 muscles in each hemi-segment of the larva innervated by 
specific motor neurons whose axons project together as a peripheral 
nerve from a ventral nerve cord neuromere (Figure 15B). Cell bodies 
located in the ventral nerve cord (VNC) project their axons through six 
main nerves consisting of ISN (intersegmental nerve, SNa (segmental 
nerve a), SNb (segmental nerve b), SNc (segmental nerve c), SNd 
(segmental nerve d) and a transverse nerve (TN) that projects to very few 
motor neurons (Pérez-Moreno & O’Kane, 2018). The neuromuscular 
junction or synapse is formed when the axons of the motor neurons reach 
the muscle surface via differentiation of specialised structures known as 
synaptic boutons. They are well studied and categorized into four types 
based on size namely :   
• Type Ib. They are glutamatergic, present in all muscles and 
are the largest measuring about 3-6µm.   
• Type Is. They are similar to 1b but smaller with a dimension of 
2-4 µm.   
• Type II boutons use as neurotransmitters glutamate and 
octopamine. They are not present in all muscles like the type I 
boutons and are the smallest with a size of 1-2 µm (Monastirioti et 
al., 1995).  
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• Type III boutons have glutamate and insulin as putative 
hormone transmitters and are present only on muscle 12. Their size 
is medium with 2-3µm dimension (Gorczyca et al., 1993). 
1.6.4 Drosophila Futsch  
The MAP1B homologue is encoded by the futsch gene in Drosophila. 
MAP1B is the first MAP to be expressed in neurons and is required for 
axonal and dendritic growth. It regulates microtubules at the 
neuromuscular junction in Drosophila. Futsch is a 575kDa protein 
containing predicted 5327 amino acids (Figure 16A). It presents a strong 
homology to the mammalian MAP1B and is recognized by the monoclonal 
antibody mAB 22c10 (Roos et al., 2000). The  central domain is highly 
repetitive with an homology to the vertebrate neurofilaments while the N 
and C terminals are homologous to the vertebrate MAP1B (Figure 16C) 
(Hummel et al., 2000). It is found in all parts of the neuron with the axon 
having the highest concentration (Bush, 1996; Robberecht & Philips, 
2013). It is composed of a heavy chain HC (300kDa) and two light chains 
LC-1 (32kDa) and LC-3 (18kDa). It has a microtubule binding domain and 
an actin binding domain both of which are found in the heavy chain 
(Cueille et al., 2007) presupposing that it could be a link between 
microtubules and microfilaments as reported by SatoYoshitake and 




         
          
Figure 16 The futsch Locus Encodes a MAP1B homolog Protein (A) The genomic organization of 
futsch and the location of the 22C10 epitope are indicated. B) The deduced Futsch protein is 5327 
amino acids in length; N- and C-terminal domains share similarity to the vertebrate MAP1B protein. The 
middle part of the Futsch protein is composed of 60 direct repeats of a 37 amino acid–long domain. The 
level of shading indicates the degree of sequence identity. A sequence comparison of regions 
designated (a) and (b) is shown in more detail is shown in C) Sequence Comparison of Futsch and 
Human MAP1B N- and C-Terminal Protein Sequences (a) shows the N-terminal 600 amino acids, and 
(b) shows the C-terminal 295 amino acids. Identical amino acids are shaded in black. (Adapted from 




Phosphorylation is the most important post translational modification of 
MAP1B and is important in maintaining its function as a microtubule 
stabilizer (Cassimeris, 2010). The embryonic nervous system presents 
defects in axonal and dendritic growth in the loss-of function allele of 
futsch (Hummel et al., 2000), while hypomorphic alleles that are viable 
present alterations in microtubule organization at the synapse. Also at the 
neuromuscular junction, a reduction in bouton number and an increase in 
bouton size were observed (Roos et al., 2000). Futsch is negatively 
regulated by the Drosophila fragile x mental retardation (dFXR) gene 
which acts as its translational repressor to regulate microtubule-
dependent synaptic growth and function (Zhang et al., 2001).  The 3-
related genes for FMR present in mammals are represented by a single 
dFXR in Drosophila. FMR and dFXR proteins show considerable 
similarities in their molecular characteristics, expression patterns and 
functions (Figure 17). Importantly, the features observed in dFXR mutants 
are consistent with synaptic defects found in human fragile X patients and 
FMR1 knock-out mice. These observations reiterate Drosophila as an 
attractive genetic model to study many diseases including Fragile X 






            
Figure 17 Protein domains in dFXR and human FMRP. The percentage similarities in amino acids 
between the homologs are indicated. Abbreviations are as follows: KH, K homology domain; NLS, 
nuclear localization signal; NES, nuclear export signal; and RGG, a motif rich in arginine and glycine 
(Adapted from Hummel et al., 2000). 
 
We have observed that the protein levels of Futsch is reduced in TBPH 
mutant flies and mutations in this protein recapitulates many phenotypes 
of the mutant flies including locomotion defects (Godena et al., 2011; 
Roos et al., 2000). Overexpression of Futsch was found to be 
neuroprotective implying disrupted cytoskeletal arrangement as part of 
the disease mechanism of ALS caused by TDP-43 dysfunction (Coyne et 
al., 2014).  
 
1.6.5 The synaptic vesicle cycle in Drosophila  
The synaptic vesicle cycle is composed of both exocytosis and 
endocytosis. Neurotransmission is effectively achieved by regulated 
exocytosis of neurotransmitters encapsulated in synaptic vesicles at the 
active zones of the nerve terminals. This is a highly specialized event that 
shares many molecular components and characteristics with the less 
specialized membrane fusion in other cells. So, the soluble N-
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ethylmaleimide-sensitive factor attachment protein receptors (SNAREs), 
the ATPase N-ethylmaleimide-sensitive factor and the Rab-GTPases, 
which are all proteins involved in the membrane fusion complex, are found 
to be highly conserved in the animal kingdom from yeast to humans. They 
are also needed for normal vesicular trafficking and synaptic activities 
(Rothman, 1994).  
Repeated rapid rounds of neurotransmission are maintained aand 
sustainable as a result of the continuous formation and fusion of the 
synaptic vesicles from and with the synaptic membranes. At the 
presynaptic terminal, activation of the SNARE protein complex is achieved 
in response to the initial influx of calcium. These proteins involved in the 
fusion of the lipid bilayers are present on both the surface of the 
presynaptic membrane and the synaptic vesicle membranes (Figure 18) 
(Jahn et al., 2003).  
SNARE proteins are classified as R-SNARE and Q-SNARE based on the 
composition of the conserved arginine or glutamine residues in the core 
of their SNARE motifs as opposed to the previous classification into v-
SNARE and t-SNARE as a result of their presence on the vesicles or 






          
Figure 18 The synaptic vesicle cycle and mechanism of recycling. (1). Formed vesicles are filled 
with neurotransmitters. (2) a synaptic vesicle pool ready for exocytosis. (3) vesicles move to the synaptic 
membrane where they dock and are  (4) primed after which a burst of calcium ions trigger (5) the fusion 
and opening of a pore. (6) Empty vesicles are endocytosed via the clathrin-mediated pathway (7) 
Vesicles are uncoated and filled with neurotransmitters to be returned to the pool or (8) recycled via 
endosomes for sorting and subsequent actions. Figure adapted from neurology.mhmedical.com  
 
Majorly, three proteins are responsible for mediating the exocytosis cycle 
of the synaptic vesicles in Drosophila. Syntaxin 1A is present in plasma 
membrane at the synaptic terminal and is involved in docking of synaptic 
vesicles. Synaptobrevin or vesicle-associated membrane protein (VAMP) 




p   
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plasma membrane. Synaptosomal nerve-associated protein 25 (SNAP-
25) is a protein responsible for the formation of tight complexes. It clusters 
the synaptic vesicles to the plasma membranes (Südhof, 2004).  
At the active zone, the interaction of Synaptobrevin, an R-SNARE protein 
with the domains of the Q-SNARE proteins Syntaxin 1 and SNAP-25 leads 
to the formation of the synaptic ‘SNARE core complex’  which drives the 
docking process of the synaptic vesicles leading to fusion with the 
presynaptic membranes (McMahon & Gallop, 2005). The SNARE core 
complex is a four helix structure formed by 2 helices of SNAP-25 and one 
each from Syntaxin 1A and Synaptobrevin. Syntaxin and Synaptobrevin 
are anchored by their C-terminal domains in their respective membranes 
while SNAP-25 is tethered to the plasma membrane via several cysteine-
linked palmitoyl chains (Martens & McMahon, 2008).  
Fused vesicles release their cargoes and the recycling process begins 
through endocytosis via different pathways of which the most used and 
studied is the clathrin-mediated endocytosis (Figure 18B2). Here, adaptor 
proteins (AP) recruit clathrin to the plasma membrane inducing 
invaginations. Subsequent fission of the synaptic vesicles from the plasma 
membranes is mediated by dynamin and endophilin. Synaptojanin 
uncoats the vesicles that are directed back to the functional pool thereby 
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allowing the empty vesicles to be recycled (Murthy & Camilli, 2003; 
Richmond & Broadie, 2002).  
The bulk endocytic pathway involving the transport and recycling of 
vesicles via specialized endosomes is less characterized (Hoopmann et 
al., 2010) (Figure 18B3). There is some evidence of a transient fusion pore 
also known as the ‘kiss and run’ recycling pathway involving closure of the 
pore immediately after cargo release into the synaptic cleft (Figure 18B1) 
(Verstreken et al., 2002, 2003). Newly endocytosed vesicles are either 
recycled to the functional pool or internalized into multivesicular bodies 
through ESCRT (endosomal sorting complexes required for transport) 
machinery and are targets for degradation (Stenmark, 2009) (Figure 18A).  
The Rab proteins are a family of small GTPases responsible for regulation 
of intracellular trafficking which includes the above described process by 
virtue of their ability to interact with the synaptic vesicles. They affect their 
specific binding to endosomes, their relations with the SNARE proteins 
and also mediate the interactions of the endosomes with the microtubules 








Figure 19 The vesicle pools in Drosophila neuromuscular junction and endocytic pathways. A 
typical NMJ in Drosophila has 200-300 active zones where endo and exocytosis occur. Both clathrin-
mediated and clathrin-independent endocytosis occur at Drosophila NMJs. The exact time courses of 
these endocytic pathways have not been determined. (adapted from (Gan & Watanabe, 2018) figure 
inclusive).  
 
Each NMJ in Drosophila contains ~180 boutons (Schuster et al., 1996) 
with each bouton having 7–41 active zones (Atwood et al., 1993). A dense 
T shaped projection called the T-bar seen on electron microscopy of fixed 
samples is the center of the active zone which is surrounded by a synaptic 
vesicle-rich area (Figure 19). Approximately 460 synaptic vesicles are 
present in a single bouton bringing the total number of vesicles to about 




180 boutons are present in this specialized synapse (Delgado et al., 2000; 
Schuster et al., 1996). The recycling pool of vesicles can be completely 
turned over in approximately 10-14s as the maximum rate of synaptic 
vesicle recycling at a normal NMJ averages about 1000 vesicles per 
second (Delgado et al., 2000; Poskanzer et al., 2006). 14% of the total 
number of vesicles constitute the recycling pool which are located at the 
periphery of the bouton, the readily releasable pool has about 0.7%  while 
the rest of the vesicles, about 85%  are the reserve pool found in the core 
of the bouton (Figure 19) (Delgado et al., 2000; Kuromi & Kidokoro, 1998; 
Muller et al., 2012; Ramaswami et al., 1994).    
 
1.7 Our Drosophila model of Amyotrophic Lateral Sclerosis 
(TBPH null flies).  
In Feiguin et al., 2009, it was described the generation of a Drosophila 
model of ALS with the deletion of the TPBH gene, which is the orthologue 
of the human TDP-43 in flies (Figure 20). Endogenous expression of the 
protein was completely abolished in these null mutants and the flies 
recapitulate many of the ALS phenotypes such as reduced life span, and 
significant locomotion impairment as a result of structural defects of the 
neuromuscular junction. Both phenotypes and NMJ structural defects 
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were recovered by the expression of both TBPH and hTDP-43 in the 
neurons of these flies  (Figure 21).   
 
Figure 20 Loss of TBPH in Drosophila impacts negatively on life span and Locomotion. (A) 
Schematics of TBPH mutant alleles. (B) Western blot  detects no endogenous protein in mutant fly 
heads (upper panel) tubulin was a loading control (bottom panel). (C) physical appearances of wild type 
controls and TBPH mutant flies are similar with no observable differences. (D) Expressing Drosophila 
or human TDP-43 transgene in the neurons recovers the reduction in life span recorded in TBPH mutant 












Figure 21 Anatomical  defects at Neuromuscular Junction of TBPH mutant Flies. (A) Confocal 
images of motoneurons presynaptic terminals at muscles 6 and 7 in wild type third instar larvae stained 
with anti-HRP antibodies, reveals the branching pattern and the presence of big (arrowhead) and small 
(arrow) synaptic boutons. (B) and (C) Similar staining and anatomical position for TBPHD23 and 
TBPHD142 homozygous larvae respectively, show reduced axonal branching pattern and number of 
synaptic boutons. (D) TBPHD23 minus third instar larvae rescued by expressing UAShTDP-43 in 
motoneurons with D42-GAL4 shows recovery of presynaptic complexity with increased formation of 
synaptic boutons and axonal terminal branching. Magnification 63. (E) Number of peristaltic waves 
observed during 2 minutes in 120 h third instar larvae. n = 20 for each genotype, error bars indicate 
S.D.; P < 0.0001 calculated by ANOVA. Adapted from (Feiguin et al., 2009).  
 
Moreover, the levels of some pre-synaptic vesicular proteins such as 
Syntaxin, Synapsin, and cysteine string protein (CSP) were reduced when 
TBPH was silenced in neurons. Also the levels of Futsch, was found to be 
down-regulated in TBPH mutant flies presupposing a possible alteration 
in the function of microtubules (Figure 22). TDP-43 has a critical role in 
the formation and maintenance of the Drosophila NMJ, a specialised 
synapse from where features of motor neuron degeneration can be seen 







Figure 22 Depletion of TBPH interferes with microtubule organization through mediation of 
Futsch action. (A) Confocal images showing futsch staining at the terminal synaptic boutons of wild 
type (Ai–Aiii), TBPHD23 (Avii–Aix), TBPHD142 (Aiv–Avi). Note the complete absence of futsch at the 
most distal, newly formed, boutons in TBPH null Arrow heads point to the apparent absence of futsch 
at the newly formed boutons which are distalmost. (Ax–Axii) Expression of TBPH protein in the neurons 
recovers futsch staining in TBPH null larvae. (B) Quantifications of futsch staining pattern in muscle 6–
7 abdominal segment II showing increased number of diffused futsch and futsch negative boutons in 
TBPH null alleles compared to wild type. n = 15 larvae. **p<0.01 and ***p<0.001 calculated by one-way 
ANOVA. (C) Western blot analysis and the respective histogram confirmed the reduced futsch 





2.0 AIM AND OBJECTIVES OF THE RESEARCH 
2.1 Aim 
The aim of the study was to characterize the Futsch/MAP1B rescue of 
locomotion defects in a Drosophila model of Amyotrophic Lateral 
Sclerosis. 
2.2 The Objectives were: 
• To investigate if silencing tbph was sufficient to exert an 
effect on Futsch levels and its role in the anatomy of the NMJ. 
• To determine the best driver for the expression of Futsch in 
the neurons of TBPH mutant flies. 
• To check if expressing Futsch in the neurons of TBPH mutant 
flies was sufficient to recover their ALS-like phenotypes with 
respect to motility, anatomy of the NMJ and levels of some 
synaptic proteins.  
• To investigate the effects of Futsch on Rab4 rescue of motility 
in TBPH mutant flies and vice versa. 
• To investigate the role of Futsch in synaptic vesicle recycling 
in TBPH mutant flies. 
• To investigate the effect of Futsch on synaptic growth 
signalling (BMP pathway) in TBPH mutant flies. 
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3.0 MATERIALS AND METHODS 
3.1 Fly stocks 
w[1118]  
Oregon R 
w[1118]; TBPHΔ23/Cyo-GFP (Feiguin et al., 2009) 
w[1118]; TBPHΔ142/Cyo-GFP (Feiguin et al., 2009) 
uas-EP10756; TBPHΔ23/Cyo-GFP (Godena et al., 2011) 
w[1118]; UAS-mCD8::GFP/Cyo (#5137, BDSC) 
w[1118]; UAS-MitoGFP/TM3SB 





w[1118]; UAS-RAB4 GFP/TM3SB 
w[1118]; TBPHΔ23/Cyo-GFP; UAS-RAB4 GFP/TM6B 




w[1118]; UAS-TBPH RNAi (#ID38377, VDRC) 
w[1118]; UAS-GFP RNAi (#9330, BDSC) 
w[1118]; UAS-GFP RNAi (#9331, BDSC) 
w[1118], P{UAS-dicer2, w[+]} (#60007, VDRC) 
        
3.2 Drosophila techniques 
3.2.1 Fly stocks and crosses  
Some of the fly stocks were prepared in other laboratories and were gifts 
from friends and colleagues, some of them were prepared during the 
course of this study while others were purchased from the Bloomington 
Drosophila stock centre (Indiana; https//bdsc.indiana.edu/), the 
Drosophila genetic resource centre (Kyoto; 
https://kyotofly.kit.jp/cgibin/stocks/index.cgi), and Drosophila stock centre 
(Vienna; https://stockcenter.vdrc.at/control/main). Stocks were stored at 
room temperature for short term use or at 18°C for long term use. They 
were flipped into new tubes weekly or bi-monthly depending on the 
temperature in which they were kept. Flies were grown in small vials 
containing fly food in small aliquots (Figure 23). Experimental crosses of 
ten females and three males per vial were maintained in an incubator with 
set conditions of 60% humidity, 25°C, 12 hours light and 12 hours dark 
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cycles.  The recipe for the fly food is written in Table 1 and the procedure 
described. 
 
            
Figure 23 An empty fly vial with fresh food. 
         
Table 1 Constituents of the Fly food and the required quantity 
Ingredients  Quantity  
yeast  1000g  
agar  100g  
cornflour  466g  
sugar  666g  
propionic acid  66ml  
water  17l  
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In summary, about 15l of the water was boiled and the yeast was 
dissolved in a small portion of the boiled water. Agar was added to the 
boiling water and stirred intermittently to prevent overflow. The cornmeal 
was dissolved in the remaining 2l of water and added to the boiling agar.  
The mixture was stirred well. The dissolved yeast was added into the 
boiling mixture and stirred periodically. The food was cooled to about 65°C 
and the propionic acid was added. Food was stirred well and aliquoted 
into small vials shown in Figure 23 while it was just warm to touch. Not 
hot! The food was allowed to cool completely (overnight was used) before 
closing each vial with cotton wool. Food was stored at 4°C until required 
for maximum of 4weeks. 
3.2.2 Larva Movement (Crawling) 
The third instar larvae known as the wandering larvae were carefully 
picked from the food, washed in a drop of clean demineralised water   and 
taken to the UV lamp microscope for selection using markers like the GFP 
or tubby. The larva were carefully selected and placed in a 6cm dish 
containing 0.7% agarose to prevent them from drying out. Each larva was 
placed in the middle of a 10cm dish containing 0.7% agarose and allowed 
30s for acclimatization. Then, the number of peristaltic movements of the 
larva in 120s was counted. A larva moves by contractile waves originating 
from the posterior segments that move anteriorly from segment to 
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segment (Figure 24). About 20-30 larvae were counted per genotype. The 
counted larvae were transferred into a fresh vial of food and allowed to 
complete their cycles. This is to ensure the right genotypes were selected 
as the eclosed flies can confirm this.           
     
Figure 24 Larval locomotion system (A) Schematics showing larval peristaltic locomotion by 
propagating waves that moves from the posterior to the anterior part of the larva segmentally. (B) Basic 
architecture of the Drosophila larval neuromuscular system. Image adapted from (Kohsaka et al., 2012) 
 
3.3 Larva NMJ immunohistochemistry 
Third instar larvae were selected as described above into 6cm plate 
containing 0.7% agarose. Each larva was washed and placed on a sylgard 
plate for dissection in a drop of HL3 solution (128mM NaCl, 2mM KCl, 
4mM MgCl2, 0.1mM CaCl2, 35.5mM Sucrose and 5mM Hepes (pH 7.2) . 
The larva was pinned at both ends and a midline incision was made with 
a spring scissors between both pins (Austerlic Insect Pins 0.1mm 
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diameter, Fine Science Tools, Germany). The internal organs were 
removed and the remaining larva wall was carefully washed with the HL3 
(Figure 25). It was then fixed using 4% PFA in PBS for about 20minutes 
except for glutamate receptors that fixation was done with methanol for 
5mins at -20°C.          
Table 2 Primary antibodies used with their dilution rate 
 
Primary Antibodies   
Name (supplier)  
Host  Dilution  
(NMJ)  
αGFP (#A11122, Invitrogen)  Rabbit  1 : 300  
αHRP (#323-005-021 Jackson)  Rabbit  1 : 150  
αHRP conjugated with alexa fluor 555 (#123-165-021 
Jackson)  
Goat 1 : 150  
αDlg (#4F3c, DSHB)  Mouse  1 : 250  
αGluRIIA (#8B4D2c, DSHB)  Mouse  1 : 15  
αFutsch (#22C10s, DSHB)  Mouse  1 : 50  
αsynapsin (#3C11-c, DSHB) Mouse  1 : 15 
αsyntaxin (#8C3-s, DSHB) Mouse  1 : 15 
αcsp (#6D6-c, DSHB) Mouse  1 : 15 
αacetylated tubulin Mouse  1 : 2000 
αGFP (#A10262, Invitrogen) Chicken 1 : 1000 
αPmad-1 (#sc12353 Santa cruz) Rabbit  1 : 1000 




Table 3 Secondary antibodies used with their dilution rate 
Secondary Antibodies 
Name (supplier)  Host  Dilution  
(NMJ)  
Alexa Fluor® 488 αmouse  
(#A11001) or αrabbit (#A11008), (Life  
Technologies)  
Goat  1 : 500  
 Alexa Fluor® 555 αmouse  
(#A21422) or αrabbit (#A21428), (Life  
Technologies)  
Goat  1 : 500  
Alexa Fluor® 647 αchicken  
(#A21449, Life  
Technologies)  
Goat 1:500 
αmouse-HRP (#32430,  
Pierce)  
Goat  1 : 150  
αrabbit-HRP (#32460,  
Pierce)  
Goat  1 : 500  
 
Larvae were kept in HL3 on ice till dissection was completed (<3hours) 
and they were washed in PBST (PBS 1x supplemented with 0.1% (v/v) 
Tween20) thrice for 5minutes each. Blocking was done for 30minutes in a 
solution of 5% NGS (Normal Goat Serum, Chemicon) in PBST. The 
blocking solution was used to dilute the primary antibodies ( 
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Table 2) and the larvae were incubated in it overnight at 4°C. The next 
day, primary antibodies were removed and the larvae were washed thrice 
for 10minutes each in PBST. They were then blocked as previously 
described and incubated for 2hrs in secondary antibodies (Alexa Fluor® 
Secondary antibodies, Life Technologies) (Table 3) diluted in the blocking 
solution. This incubation was in the dark and at room temperature. Larvae 
were washed in PBST thrice for 20minutes each to remove excess 
antibodies and they were then incubated in slowfade®Gold antifade (Life 
Technologies) reagent overnight at 4°C. The Larvae were then mounted 
in slowfade on glass slides, cover-slipped and scanned by a Carl Zeiss 













        





3.3.1 Shape of Boutons 
Boutons of the NMJs stained with HRP were used for this analysis. The 
NMJs were acquired with the airyscan confocal microscope using exactly 
the same settings for all genotypes involved. The bouton was categorized 
as regular when the circumference was round and smooth with an equal 
or almost equal axes. It was irregular when the circumference was not 
smooth and in a shape other than round with obviously unequal axes 
(Figure 26).   
 
Figure 26 Regular and Irregular boutons. Regular boutons are circular and irregular boutons appear 
in different shapes and sizes. (Adapted from Strah, 2019). 
 
3.3.2 Number of Branches 
Primary, secondary and tertiary branches of a HRP-stained NMJ were all 
counted together and recorded (Figure 27) using images taken with the 





Figure 27 Schematic representation of the different types of branches in a Larva NMJ adapted 
from Strah, 2019.  
 
3.4 Pre and post synaptic markers quantification 
The larvae double or triple labelled with HRP and antibodies against pre 
and or post synaptic markers using the previously described 
immunohistochemical methods were used. Confocal images of the 
involved genotypes were taken at fixed settings using the 63X oil objective 
lens and processed using imagej software. Only the boutons of NMJs 
between muscles 6 and 7 in the second and third abdominal segments of 
each larva were considered (Figure 28). Using imagej, each bouton was 
marked as a region of interest (ROI) on the HRP-stained image of the 
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NMJ and the intensities were measured. These ROIs are then used to 
measure the intensities of the same areas (boutons) on the marker-of-
interest’s image. The maximum intensities of the makers were taken and 
normalised against the HRP values. The obtained ratios were statistically 
analysed using Microsoft excel and Graphpad prism. 
 
 
Figure 28 Location of the muscles 6 and 7 in the abdominal segments of a dissected larva. 




3.5 FM1-43 labelling of synaptic vesicle trafficking 
(N-(3triethylammoniumpropyl)4(4(dibutylamino)styryl)pyridinium 
dibromide) FM1-43 is a styryl dye that is used to visualize the localization 
and recycling of the vesicles at synapses (Verstreken et al., 2008). This 
protocol was for live imaging and all solutions were prepared and used 
fresh (Table 4). 
            
Table 4 Recipe for the preparation of HL3 solutions 
HL3 for Dissection HL3 for FM1-43 
110Mm NaCl 25Mm NaCl 
5mM KCl 90mM KCl 
10mM NaHCo3 10mM NaHCo3 
5mM Hepes 5mM Hepes 
35mM Sucrose or 30mM sucrose+ 5mM 
Threalose 
35mM Sucrose or 30mM sucrose+ 5mM 
Threalose 
10mM MgCl2 10mM MgCl2 
0.5M CaCl2 
Bring PH to 7.2 Bring PH to 7.2 
 
Each larva was quickly dissected in HL3 as previously described ensuring 
that the motor neurons emerging from the ventral cord were cut. 
Incubation for primary stimulation was done at room temperature in the 
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dark using the stimulation solution (1ml HL3 for FM1-43, 1μl FM1-43 from 
a 4mM stock, and 3μl CaCl2 from a 0.5M stock) for 1minute. Larva was 
then washed 5times in HL3 for dissection for 1 minute each to remove the 
excess dye that was not incorporated. At the 3rd wash, HRP conjugated 
(1: 150) was diluted in the HL3 to highlight the synaptic boutons. 
Incubation time was 3minutes. At the end of the fifth wash, a generous 
amount of HL3 was added to the larva in the sylgard plate and we 
proceeded to the Nikon microscope for live imaging of the synaptic 
boutons at X40 and X63. Again, only the NMJs between muscle 6 and 7 
in the second and third abdominal segments were considered. This whole 
process was termed “Loading” and it corresponds to endocytosis. After 
the acquisitions of the “loading” images, the larva was drained and again 
stimulated in the dark at room temperature using the stimulation solution 
(without FM1-43) for 10minutes. It was then washed 5 times for 1 minute 
each. This process corresponds to exocytosis and was termed 
“Unloading”. Live images of the unloaded boutons were taken immediately 
after the fifth wash in excess HL3. Care was taken to image the same 
NMJs that were “loaded” using exactly the same settings of the 
microscope. All the images were processed using imagej software and 
the maximum intensity of the FM1-43 dye in both loading and unloading 
were recorded for each bouton. Graphpad prism and Microsoft excel were 
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used for statistical analysis of the generated values. 10-15 larvae per 
genotype involved were tested and imaged. 
3.6 Isogenization of TBPH stocks to generate clean TBPH null 
flies 
Since creating the TBPH mutant flies by Feiguin et al., 2009, the flies have 
been in constant use in the laboratory and may have acquired some 
mutations or other modifications in their genome to aid survival. Thus, the 
need to isogenize the stocks arose as we intend to have the flies on the 
same genetic background. Also, to ensure that the tbph deletion is the 
only mutation present in the TBPH mutant flies. The process which 
involved back-crossing of the male heterozygous flies with virgins of the 
genotype of their mothers (in this case, was a balancer, Lpin/CyoGFP) is 
depicted in Figure 29. The back-crosses were done 8times and at the end, 
genomic DNA extraction confirmed the deletion of tbph in both mutants. 
So, only one of the resultant new stocks was expanded as four identical 
experiments for each genotype were set.  The stocks were expanded (one 
each for Δ23, Δ142 and w1118) and the protocol below to collect clean 





Figure 29 Schematics showing steps involved in the preparation of clean TBPH mutant flies. 
 
The collection plates garnished with a drop of yeast paste were prepared 
fresh using the egg media (Table 5) and each genotype (Δ23/CyoGFP, 
Δ142/CyoGFP and w1118) had a plate correctly labelled fixed to a 
collection cage containing the corresponding flies for mating (70 females 
and 30 males). The plates filled with embryos were collected after every 
12hours and kept in the incubator at 25°C. After 72hours, the GFP-
negative larvae for each genotype were selected and placed into vials of 
fly food correctly labelled. The vials containing maximum of 25larvae each 
were incubated at 25°C and allowed to complete metamorphosis into adult 
flies. The heads of these flies were collected and stored in RNAlater 
solution.   
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               Table 5 Constituents of the Fly egg food-media and the required quantity 
Drosophila egg media 
400ml distilled water 
57.6ml apple juice 
14.08g agarose 
Stirred well 
Autoclaved for 1hour in the kitchen 
Left to cool and stirred 
3.2ml propionic acid and 80 nipargin were added 
Aliquoted into 6cm collection plates. 
 
3.7 Statistical analysis 
This was done using Microsoft excel and Graphpad prism v5.1. One-way 
ANOVA with Bonferroni’s post-hoc, Krushka Wallis with Dunn’s post-hoc, 
T-test with Mann-Whitney and Wilcoxon corrections were applied as 
statistical tests as required. Values are expressed as mean and standard 
error of mean (SEM) in all figures. P<0.05 was taken to be statistically 






4.1 The level of Futsch was reduced at the NMJ in TBPH mutant 
flies 
As published in the reports of Godena et al., 2011, the level of Futsch is 
reduced in TBPH mutant flies as we observe at the beginning of this thesis 
work. Our observations reported in Figure 30 shows a significant reduction 
of Futsch staining in TBPH mutants when compared with all other 
genotypes. In addition, it was evident that Futsch reached the terminal 
boutons in all the genotypes depicted except in the case of TBPH null 
mutant. There was also a significant difference in the levels of Futsch in 
the Futsch rescue group compared with the control that was wildtype for 
TBPH, where Futsch level was significantly lower than in the rescue 























































Figure 30 Futsch was reduced at the NMJ of TBPH mutant flies. Confocal images showing the 
NMJs between muscles 6 and 7 double-labelled with anti- HRP (in green) and anti Futsch (in red). Note 
the Futsch staining at the terminal boutons in all the groups except the tbph mutant where it is absent 
(white arrow). Graph shows the quantification of Futsch intensity in the boutons normalized on HRP. 
Genotypes: Elav-gal4/+ (Control), tbph∆23elav-gal4/tbph∆23; UAS-gfp-mcd8/+ (tbph mutant),  
tbph∆23elav-gal4/UAS-tbph∆23 (tbph rescue)  and UAS-Ep10751; tbph∆23elav-gal4/tbph∆23 (Futsch 
rescue) N=25 per genotype. Scale bar is 20µm. Error bars are SEM. ***p<0.0001 as calculated using 
ANOVA with Bonferroni’s correction. 
 
4.2 Silencing TBPH in neurons produced similar phenotypes to 
TBPH mutant flies with respect to Futsch. 
Having observed a reduced level of Futsch at the NMJ of TBPH mutant 
flies, we decided to check if silencing of TBPH in neurons rather than 
complete absence is sufficient to exert the same effect on the Futsch 
protein level at the NMJ. Therefore, we silenced TBPH in neurons using 
RNAi against TBPH while RNAi against GFP was used as a control. Both 
larva motility and the structure of their NMJs were analysed. 
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4.2.1 Larva motility was impaired when TBPH was silenced in 
neurons   
As shown in Figure 31, a motility defect was observed upon TBPH  
silencing in neurons similar to null TBPH mutants. The larval movement 
was significantly slower than the control where TBPH was at a wildtype 
level. The movement reduction observed was approximately 50% of the 
control. 











































Figure 31 Motility of larva was impaired when TBPH was silenced in neurons. Larva peristaltic 
movements were observed and recorded in 120s for each larva. Genotypes: Dicer(X); Elav-gal4/+; 
UAS-SiRNA-gfp/+ (Control) and Dicer(X); Elav-gal4/+; UAS-Tbph-RNAi/+ (Tpbh-RNAi). N=30 per 
genotype.  Error bars are SEM. ***p<0.0001 as calculated using t-test. 
 
 
4.2.2 The number of branches and boutons of the NMJ were 
reduced following TBPH silencing in neurons  
The NMJ was further characterised by evaluating possible alterations in 
the number of branches and boutons. Figure 32 shows a reduction in the 
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number of branches of the NMJ from 100% to 70% and the number of 
boutons to 68%. The shape of the boutons was also negatively affected 
(Figure 33). There was almost a double increase in the percentage of 
irregular boutons (about 56%) when TBPH was silenced in neurons as 
compared to the control that had 32% irregular boutons.  
  
































      
Figure 32 The number of branches was reduced at the NMJ when TBPH was silenced in neurons. 
Panel shows representative confocal images of the NMJs between muscles 6 and 7 stained with anti- 
HRP. Graph shows the quantification of the branches. Genotypes: Dicer(X); Elav-gal4/+; UAS-SiRNA-
gfp/+ (Control) and Dicer(X); Elav-gal4/+; UAS-Tbph-RNAi/+ (Tpbh-RNAi). Scale bar is 10µm. N= 25 
per genotype.  Error bars are SEM. **p<0.001 as calculated using t-test. 
 











































Figure 33 The number and shape of boutons were affected when TBPH was silenced in neurons. 
Left graph shows the number of boutons per NMJ and the right graph shows the quantification of the 
shape of the boutons into regular and irregular all of which were negatively impacted and statistically 
significant. Genotypes: Dicer(X); Elav-gal4/+; UAS-SiRNA-gfp/+ (Control) and Dicer(X); Elav-gal4/+; 
UAS-Tbph-RNAi/+ (Tpbh-RNAi). N= 25 per genotype.  Error bars are SEM. ***p<0.001 as calculated 
using t-test. 
 
4.2.3 The level of Futsch at the NMJ was reduced when TBPH 
was silenced in neurons 
Having observed a motility defect upon TBPH silencing similar to TBPH 
deficiency, we proceeded to larva dissection and NMJ staining for Futsch. 
As depicted in Figure 34, a significant reduction in the level of Futsch was 
detected for TBPH silencing. Futsch level dropped from 1.0 to about 0.84. 
Noteworthy is the distribution of Futsch that was absent at the terminal 
boutons when TBPH was silenced also similar to what is observed in the 






































































Figure 34 The level of Futsch was reduced at the NMJ when TBPH was silenced in neurons. 
Panel shows representative confocal images of the NMJs between muscles 6 and 7 double-labelled 
with anti- HRP (in green) and anti Futsch (in red). Note the futsch staining at the terminal bouton present 
in the control and absent when tbph was silenced (white arrow). Genotypes: Dicer(X); Elav-gal4/+; UAS-
SiRNA-gfp/+ (Control) and Dicer(X); Elav-gal4/+; UAS-Tbph-RNAi/+ (Tpbh-RNAi). Graph shows 
quantification of Futsch intensity in the boutons normalized on HRP. N= 30 per genotype. Scale bar is 
20µm. Error bars are SEM. ***p<0.0001 as calculated using t-test. 
 
4.3 Larva motility was significantly improved with expression of 
Futsch in TBPH mutant flies. 
Having observed that the silencing of TBPH exclusively in the neurons is 
sufficient to exert a detrimental effect on Futsch at the NMJ, we decided 
to increase Futsch level by expressing it in the neurons of TBPH mutant 
flies by means of several drivers (Figure 35 and Figure 36) and performing 
crawling assay of third instar larvae to verify if Futsch expression might 
recover the TBPH null motility phenotype. Several drivers were tested in 



















































Figure 35 Overexpression of Futsch with pan-neuronal drivers in TBPH mutant flies recovers 
larva motility defect. This was done using the pan-neuronal drivers Elav-gal4 and nSyb-gal4. A partial 
recovery of the motility defect was observed when compared with the control in 120seconds. 
Genotypes: Elav-gal4/+ (Control), tbph∆23elav-gal4/tbph∆23; UAS GFP-mCD8/+ (Tpbh mutant) and is 
EP10751; tbph∆23elav-gal4/tbph∆23 (Futsch rescue) nSyb-gal4/+ (Control) tbph∆23nSyb-
gal4/tbph∆23; UAS GFP-mCD8/+ (Tpbh mutant) and EP10751; tbph∆23nSyb-gal4/tbph∆23 (Futsch 
rescue) Error bars are SEM. N= 30 per genotype.  ***p<0.0001 as calculated using ANOVA with 
Bonferroni’s correction. 
 
Both of the pan neuronal drivers Elav-gal4 and nSyb-gal4 used for Futsch 
expression produced a significant rescue of the motility defects seen in 
TBPH mutant flies (65% and 60% respectively, Figure 35). The motor-
neuron specific drivers Ok6-gal4 and D42-gal4 were also used and they  
resulted in a lesser rescue of motility defect that was also significant (48% 
and 45% respectively, Figure 36). In conclusion, the pan neuronal drivers 
performed better than the motor-neuron specific drivers. Since Elav-gal4 
was the driver with the best rescue, we selected it as the driver of choice 
for subsequent experiments (Figure 35 left graph).  
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Nevertheless, it is imperative to note that all the drivers produced a 
significant recovery of the motility defect of TBPH mutant flies when 
expressing Futsch rather than GFP. So, we can postulate that Futsch has 
a positive impact on larva motility when expressed even in a subset of 
motor neurons. 














































Figure 36 Overexpression of Futsch with motor-neuron specific drivers in TBPH mutant flies 
recovers larva motility defect. This was done using the motor neuron specific drivers ok6-gal4 and 
D42-gal4. A partial recovery of the motility defect was observed when compared with the control in 
120seconds. Genotypes: OK6-gal4/+ (Control), tbph∆23OK6-gal4/tbph∆23; UAS GFP-mCD8/+ (Tpbh 
mutant) and  EP10751; tbph∆23OK6-gal4/tbph∆23 (Futsch rescue). D42-gal4/+ (Control), tbph∆23D42-
gal4/tbph∆23; UAS GFP-mCD8/+ (Tpbh mutant) and EP10751; tbph∆23D42-gal4/tbph∆23 (futsch 
rescue). Error bars are SEM. N= 30 per genotype. ***p<0.0001 as calculated using ANOVA with 
Bonferroni’s corrections.   
 
The control flies that were wildtype for TBPH, performed significantly 
better at 100% (across all the drivers) than the Futsch recovery group 
which was not surprising as only the expression of TBPH is expected to 
produce a full recovery. However, the statistical significant difference 
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between the performances of the mutants and the Futsch rescue group 
was sufficient to report a rescue.  
4.5 The structural integrity of the NMJ was recovered in TBPH 
mutant flies expressing Futsch in their neurons 
Following the promising results obtained with the third instar larva 
peristaltic movements of TBPH mutant flies expressing Futsch, we 
proceeded to dissection in order to check their NMJs. As expected, there 
was significant rescue of the anatomy of the NMJ in the mutants when 
they expressed Futsch as compared to controls (Figure 37). Both the 
shape and number of boutons were rescued as observed from the 




    
Figure 37 The Anatomy of the NMJ was recovered in TBPH mutant flies expressing Futsch. The 
representative confocal images showing the NMJs between muscles 6 and 7 labelled with HRP. Top 
panel shows the recovery of shape. Note the round shape of the terminal boutons in the control and 
Futsch rescue groups which is absent in the mutant.  Bottom panel shows the full NMJs. The recovery 
of the branching and whole junction integrity is apparent. Genotypes: Elav-gal4/+ (Control), 
tbph∆23elav-gal4/tbph∆23; UAS GFP-mCD8/+ (Tpbh mutant) and EP10751; tbph∆23elav-
gal4/tbph∆23 (Futsch rescue). Scale bar is 20µm.  N= 30 per genotype. 
 
Feiguin et al., 2009 reported mis-shaped boutons as a characteristic of 
TBPH mutant flies. We observed this feature (Figure 37 top panel) and in 
fact,  TBPH mutant flies expressing GFP had the highest number of 
irregular (mis-shaped) boutons (about 85% on average) when compared 
with Futsch expressing larvae (about 62%) and the control flies that were 
wildtype for TBPH (about 29%). Reduced number of branches and 
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boutons were also reported as features of TBPH mutant flies. Both 
features were significantly rescued by Futsch expression in TBPH mutant 
flies. From 68% to 96% for branches and 63% to 95% for the bouton 
number (Figure 38). It is worthy to note that there was no statistical 
significance between the control flies that were wildtype for TBPH at 100% 
and the TBPH mutant flies expressing Futsch at 96% and 95% 
respectively for the branches and bouton number. This implies a more 
than partial recovery of the branches and boutons, an indication of growth 








                
                  
Figure 38 The number of branches and boutons of the NMJ were recovered in TBPH mutant flies 
expressing Futsch.  Top panel graphs show the normalized quantification of the Bouton numbers and 
Branches both of which were recovered by Futsch. Bottom panel graphs show the quantification of the 
boutons with respect to shape as regular and irregular. The mutants had the lowest number of regular 
bouton which were partly recovered by the expression of Futsch. Genotypes: Elav-gal4/+ (Control), 
tbph∆23elav-gal4/tbph∆23; UAS GFP-mCD8/+ (Tpbh mutant) and EP10751; tbph∆23elav-
gal4/tbph∆23 (Futsch rescue). Error bars are SEM. N= 30 per genotype. *p<0.01 **p<0.001 



























































































































































4.6 Larva motility was not improved in TBPH mutant flies 
expressing Tau 
We decided to check if the results obtained with Futsch with respect to 
rescue of motility will be similar to that of Tau by virtue of both proteins 
being microtubule associated proteins in the same “Classical” group. So, 
we expressed Tau in the neurons of TBPH mutant flies and performed a 
crawling assay of the third instar larvae. The graph in Figure 39 reports 
the observation made from this experiment. There was no difference 
between the TBPH mutant flies and those that expressed Tau. So, there 
was no recovery of the motility. Interestingly, when the larvae were 
dissected and the NMJs checked, there was a good recovery of the 
anatomy of the NMJ in TBPH mutant flies expressing Tau (Figure 39 
micrograph). We can then say that we have an anatomical rescue similar 
to that observed when the flies expressed Futsch but the rescue was not 
functional because the larvae still retained their motility defects in contrast 
to the rescue observed with Futsch. This reiterate the fact that the rescue 
obtained with the expression of Futsch is not only associated to its 
function as a microtubule associated protein but also probably because it 
is involved in a unique mechanism devoid of Tau’s action. 
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Figure 39 Overexpression of Tau in the neurons of TBPH mutant flies did not recover motility 
defect in Larvae. This was done using 3rd instar larvae motility assay and no recovery of motility was 
observed when compared with the control (w1118) in 120seconds as seen in the graph. Micrographs 
show representative images from the NMJ between muscles 6 and 7 labelled with with anti-HRP. 
Recovery of the anatomy of the junction with respect to branches and boutons is apparent.  Error bars 
are SEM. N= 30 per genotype. (Courtesy in conjunction with Giulia Romano).  
 
4.7 Futsch recovers the levels of some pre-synaptic vesicular 
proteins at the NMJ in TBPH mutant flies         
Having observed both anatomical and functional recoveries of the NMJs 
with Futsch expression in TBPH mutant flies, we proceeded to check 
some pre-synaptic proteins using immunohistochemistry. These proteins 
More so, there is alteration in the level of Futsch protein in the spinal cords of ALS patients. (42) 








were reported by Romano et al., 2014 to be downregulated in TBPH 
mutant flies and they include synapsin, syntaxin, CSP and acetylated 
tubulin (Godena et al., 2011). All of which were recovered in TBPH mutant 
flies expressing Futsch in varying degrees.         















































Figure 40 The level of synapsin was rescued in TBPH mutant flies expressing Futsch. Panels are 
representative confocal images showing the NMJs between muscles 6 and 7 double-labelled with anti-
HRP (in green) and anti-synapsin (in red). Note the intensity of the synapsin staining. Graph shows 
quantification of synapsin intensity in the boutons normalized on HRP.  Genotypes: Elav-gal4/+ 
(Control), tbph∆23elav-gal4/tbph∆23; UAS GFP-mCD8/+ (Tpbh mutant) and EP10751; tbph∆23elav-
gal4/tbph∆23 (Futsch rescue). Scale bar is 20µm. N=30 per genotype.  Error bars are SEM. ***p<0.0001 
**p<0.001 as calculated using ANOVA with Bonferroni’s correction. 
 
Figure 40 shows the observation made when the NMJs were stained for 
synapsin. There was a significant rescue of synapsin levels when the flies 
expressed Futsch (about 0.87) compared to when they expressed GFP 
(about 0.73). The control flies that were wildtype for TBPH were 1.00 and 
were significantly greater than both previous groups. 
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Figure 41 The level of Csp was rescued in TBPH mutant flies expressing Futsch. Panels are 
representative confocal images showing the NMJs between muscles 6 and 7 double-labelled with anti-
HRP (in green) and anti-Csp (in red). Note the intensity of the Csp staining. Graph shows quantification 
of Csp intensity in the boutons normalized on HRP. Genotypes: Elav-gal4/+ (Control), tbph∆23elav-
gal4/tbph∆23; UAS GFP-mCD8/+ (Tpbh mutant) and EP10751; tbph∆23elav-gal4/tbph∆23 (Futsch 
rescue). Scale bar is 20µm. N=25 per genotype. Error bars are SEM. ***p<0.0001 **p<0.001.  as 
calculated using ANOVA with Bonferroni’s correction. 
 
The level of Csp was also rescued when Futsch was expressed in TBPH 
mutant flies (about 0.83) compared to when they expressed GFP (about 
0.71). The control flies that were wildtype for TBPH at 1.00 were 

















































   
Figure 42 The level of syntaxin was rescued in TBPH mutant flies expressing Futsch. Panels are 
representative confocal images showing the NMJs between muscles 6 and 7 double-labelled with anti-
HRP (in green) and anti-syntaxin (in red). Note the intensity of the syntaxin staining. Graph shows 
quantification of syntaxin intensity in the boutons normalized on HRP. Genotypes: Elav-gal4/+ (Control), 
tbph∆23elav-gal4/tbph∆23; UAS GFP-mCD8/+ (Tpbh mutant) and EP10751; tbph∆23elav-
gal4/tbph∆23 (Futsch rescue). Scale bar is 20µm. N= 25 per genotype. Error bars are SEM. ***p<0.0001 
ns= not significant as calculated using ANOVA with Bonferroni’s correction. 
 
There was a complete recovery of syntaxin when TBPH mutant flies 
expressed Futsch because there was no significant difference between 
the Futsch rescue group (about 1.04) and the control flies that were 
wildtype for TBPH (about 1.00). Both groups were expressing significantly 






















































Figure 43 The level of acetylated tubulin was rescued in TBPH mutant flies expressing Futsch. 
Panels are representative confocal images showing the NMJs between muscles 6 and 7 double-labelled 
with anti-HRP (in green) and anti-acetylated tubulin (in red). Note the intensity of the acetylated tubulin 
staining. Graph shows quantification of acetylated tubulin intensity in the boutons normalized on HRP. 
Genotypes: Elav-gal4/+ (Control), tbph∆23elav-gal4/tbph∆23; UAS GFP-mCD8/+ (Tpbh mutant) and 
EP10751; tbph∆23elav-gal4/tbph∆23 (Futsch rescue). Scale bar is 20µm. N= 30 per genotype.  Error 
bars are SEM. ***p<0.0001 ns= not significant as calculated using ANOVA with Bonferroni’s correction. 
 
In Figure 43, we report the observations made when NMJs were stained 
for acetylated tubulin. There was a complete recovery of acetylated tubulin 
when TBPH mutant flies expressed Futsch (about 1.10) because there 
was no statistical significance when compared with the control flies that 
were wildtype for TBPH  (at 1.00). TBPH mutant flies expressing GFP was 





4.8 Futsch recovers the levels of some post-synaptic proteins 
at the NMJ of TBPH mutant flies 
The levels of Dlg and glutamate receptors IIA (GluRIIA) were checked 
given the positive observations made with the pre-synaptic proteins. Both 
protein levels were recovered with Futsch expression in TBPH mutant 
flies.      










































Figure 44 The level of Dlg was rescued in TBPH mutant flies expressing Futsch. Panels are 
representative confocal images showing the NMJs between muscles 6 and 7 double-labelled with anti-
HRP (in green) and anti-dlg (in red). Note the intensity of dlg staining. Graph shows quantification of 
dlg intensity in the boutons normalized on HRP. Genotypes: Elav-gal4/+ (Control), tbph∆23elav-
gal4/tbph∆23; UAS GFP-mCD8/+ (Tpbh mutant) and EP10751; tbph∆23elav-gal4/tbph∆23 (Futsch 
rescue). Scale bar is 20µm. N= 30 per genotype.  Error bars are SEM. ***p<0.0001 **p<0.001 ns= not 
significant as calculated using ANOVA with Bonferroni’s correction. 
 
Dlg level was significantly recovered in TBPH mutant flies expressing 
Futsch (about 0.65) compared to when they expressed GFP (about 0.54). 
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The control flies that were wildtype for TBPH was 1.00 and was greater 
than both previous groups (Figure 44). 













































Figure 45 The level of glutamate receptors IIA was rescued in TBPH mutant flies expressing 
futsch. Panels are representative confocal images showing the NMJs between muscles 6 and 7 
double-labelled with anti-HRP (in green) and anti-GluRIIA (in red). Note the intensity of GluRIIA staining. 
Graph shows quantification of GluRIIA intensity in the boutons normalized on HRP. Genotypes: Elav-
gal4/+ (Control), tbph∆23elav-gal4/tbph∆23; UAS-GFP-mCD8/+ (Tpbh mutant) and EP10751; 
tbph∆23elav-gal4/tbph∆23 (Futsch rescue). Scale bar is 20µm. N=25 per genotype.  Error bars are 
SEM. ***p<0.0001 as calculated using ANOVA with Bonferroni’s correction. 
 
Figure 45 shows a significant rescue of GluRIIA when TBPH mutant flies 
expressed Futsch (0.62) compared to when they expressed GFP (about 
0.44). The control in wildtype condition for TBPH was significantly better 
than both groups at 1.00.   
4.9 More mitochondria were localized at the NMJ in TBPH 
mutants.  
In order to attempt to document axonal transport indirectly, we checked 
the localization of mitochondria at the NMJ by IHC using the mean 
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intensity of mito-GFP (a mitochondria import signal fused with GFP) 
staining. Mitochondria are perfect cargoes that must be transported from 
the soma to the NMJs where they are required to power synaptic 
processes that are highly energy intensive. In addition, defective 
mitochondria must find their way back to the soma for proper degradation. 
So, mitochondria are thought to be a good read-out of axonal transport. 
TBPH mutants have a significantly higher intensity of mito-GFP than the 
control that is wildtype for TBPH (Figure 46) averaging 1.14 and 1.00 
respectively. 






































Figure 46 More mitochondria were present at the NMJ in TBPH mutant flies. Panel shows 
representative confocal images of the NMJ between muscles 6 and 7 double-labelled with HRP (in red) 
and mito-gfp (in green). The graph shows quantification of the mito-GFP intensity in the boutons and 
the mutants have a significant higher mean intensity than the control. Genotypes: Elav-gal4/+; UAS 
mito-GFP/+ (Control) and tbph∆23elav-gal4/tbph∆23; UAS mito-GFP/+ (Tbph mutant). Scale bar is 
20µm. N= 25 per genotype. Error bars are SEM.  ***p<0.0001  as calculated using t-test. 
 
Also, the expression of mito-GFP did not alter the typical TBPH mutant 
locomotion defects as reported in the crawling assay (Figure 47). The 
control with wildtype condition for TBPH moved twice as fast as the mutant 
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with about 100 movements in 120s as compared to the mutants that had 
43 movements in the same time frame.  






































Figure 47 Motility of Larva was impaired in TBPH mutant flies expressing mito-GFP. Larva 
peristaltic movements were observed and recorded in 120s for each larva. Genotypes: Elav-gal4/+; 
UAS-mito-GFP/+ (Control) and tbph∆23elav-gal4/tbph∆23; UAS-mito-GFP/+ (Tbph mutant). N= 30 per 
genotype.  Error bars are SEM. ***p<0.0001 as calculated using t-test. 
 
4.10 Analysis of the synaptic vesicle recycling at the Drosophila 
NMJ using FM1-43 dye.  
FM1-43 is a fluorescent dye used as a synaptic vesicle marker to visualise 
and analyse endocytosis from the presynaptic membrane and also to 
study the exocytosis kinetics of pre-labelled vesicles. The process of 
synaptic vesicle recycling involves simultaneously both endocytosis which 
corresponds to loading of the dye and exocytosis which corresponds to 
unloading of the dye. For the test experiment, a Chemical (KCl) 
stimulation was achieved by immersing dissected larvae (w1118) in a 
“stimulation fluid” that is required to “load” FM1-43 into vesicles in a 
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process simulating endocytosis. As control experiment, more dissected 
larvae (w1118) were immersed in a “dissection fluid” that was designed to 
be non-stimulatory and the process of loading was initiated. Comparing 
the intensities of FM1-43 in these two experiments, Loading was more 
successful in the experiment using the stimulation fluid than in the one 





















































Figure 48 Quantification of FM1-43 intensity in synaptic boutons during “loading” in w1118 flies. 
Using the dissection solution in place of the stimulation fluid loaded a significantly lesser amount of 
FM1-43. N= 20.  Error bars are SEM 
 
Approximately half the quantity of FM1-43 loaded using the stimulation 
fluid was loaded when the dissection solution was used. The four 
experiments ran with these two fluids in  w1118 were very consistent as 
they all produced similar results (Figure 48). Thus, we proceeded to the 
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experiments of checking the synaptic vesicle recycling in w1118 and 
TBPH mutant flies using the stimulation fluid. 
4.11 The synaptic vesicle recycling is impaired in TBPH mutant 
flies. 
In order to test the role of TBPH in the exo-endocytic cycling of synaptic 
vesicles, we decided to check the process of vesicle recycling through the 
use of FM1-43. This cycle was stimulated and monitored. Recordings 
were reported in Figure 49. Both genotypes, the control (w1118) and 
TBPH mutant  “loaded” and “unloaded” at significantly different rates. The 
control had a turnover of about 42% while TBPH mutant larvae had about 
24%, almost half that of the control.   
In more details, while the control loaded 100% of vesicles at the synapse 
and unloaded about 58% of that leaving approximately 42% in the boutons 
(Figure 49), the TBPH mutant flies on the other hand, loaded about 84% 
of boutons and unloaded approximately 60% of that leaving approximately 
24% in the boutons. So, the turnover of the synaptic vesicle recycling was 


















































Figure 49 TBPH mutant flies have impaired synaptic vesicle recycling. Panel shows images from 
live microscopy of the NMJ between muscles 6 and 7 visualized by FM1-43 dye. Graph shows the 
quantification of FM1-43 intensity in the boutons as they undergo endocytosis (Load) and exocytosis 
(Unload). Note the blue arrows showing the sub-boutonic structures. N= 20 per genotype. Error bars 
are SEM. ***p<0.0001 as calculated using t-test. 
 
Noteworthy, we observed the presence of some structures in the boutons 
shaped like “doughnuts” (blue arrows in Figure 49) that were deeply 
perfused with FM1-43 dye resulting with high intensities as reported in 
Figure 50. The control had significantly greater number of these structures 
than the TBPH mutant flies. Consequently, TBPH mutant flies had 



















































Figure 50 Quantification of localization of FM1-43 in synaptic boutons. TBPH mutant flies had 
lesser number of sub-boutonic structures. N= 20 per genotype.  Error bars are SEM. ***p<0.0001 as 
calculated using t-test. 
 
4.12 The synaptic vesicle recycling was improved in TBPH 
mutant flies expressing Futsch 
Having recovered in the Futsch rescue flies, synaptic proteins such as 
synapsin, syntaxin and Csp that are associated with the vesicles at the 
synapse, we proceeded to check if there would be a recovery of the 
impairment observed in the synaptic vesicle recycling of TBPH mutant 
flies by Futsch. There was a rescue of the vesicle recycling in the mutants 
as there was a significant improvement in the turnover rates of the 
vesicles (Figure 51). The control that was wildtype for TBPH had a 
turnover of about 45%, the TBPH mutant had about 20%, the rescue by 
TBPH and Futsch had 43% and 35% respectively. So, we report a 





























































Figure 51 Synaptic vesicle recycling was improved in TBPH mutant flies expressing Futsch. 
Panel shows images from live microscopy of the NMJ between muscles 6 and 7 visualized by FM1-43 
dye. Graph shows the quantification of FM1-43 intensity in the boutons as they undergo endocytosis 
(Load) and exocytosis (Unload). Note the blue arrows showing the sub-boutonic structures. Genotypes: 
Elav-gal4/+ (Control), tbph∆23elav-gal4/tbph∆23; UAS-GFPmCD8/+ (tbph mutant),  tbph∆23elav-
gal4/UAS-tbph∆23 (tbph rescue)  and EP10751; tbph∆23elav-gal4/tbph∆23 (Futsch rescue). Scale bar 
is 20µm. N= 20 per genotype.  Error bars are SEM. ***p<0.0001 **p<0.001 ns= not significant as 
calculated using ANOVA with Bonferroni’s correction 
 
Also, there was a recovery of the sub-boutonic structures with 
sequestrated FM1-43 in TBPH mutant flies expressing Futsch. About 72% 
of boutons had no sub-boutonic structures in TBPH mutant flies compared 
to about 34% in the mutants expressing Futsch. The percentages of 
boutons having no sub-boutonic structures of FM1-43 in the control that 
were wildtype for TBPH and in the mutants expressing TBPH (TBPH 
rescue) were 25% and 30% respectively (Figure 52). So, Futsch exerted 
an improvement in this regard too. 
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Figure 52 Quantification of localization of FM1-43 in synaptic boutons. TBPH mutant flies had a 
significant lesser number of boutons with sub-boutonic structures. Genotypes: Elav-gal4/+ (Control), 
tbph∆23elav-gal4/tbph∆23; UAS-GFP-mCD8/+ (tbph mutant), tbph∆23elav-gal4/UAS-tbph (tbph 
rescue)  and EP10751; tbph∆23elav-gal4/tbph∆23 (Futsch rescue) N=25 per genotype. N= 20 per 
genotype. Error bars are SEM. ***p<0.0001, ns= not significant as calculated using ANOVA with 
Bonferroni’s correction. 
 
4.13 The Rab4 and Rab5 rescue of TBPH mutant flies defects  
4.13.1 Rab4-GFP rescues motility defect in TBPH mutant flies 
Taking into consideration the results obtained with the synaptic vesicle 
recycling and the recovery of acetylated tubulin levels, a key player of the 
cytoskeleton, we proceeded to some proteins of vesicular trafficking, 
Rab4 and Rab5, both of which were GFP-tagged. TBPH mutant flies 
expressing Rab4-GFP in their neurons significantly improved their larvae 
motility while those expressing Rab5-GFP did not (Figure 53) as there was 
no significant difference between the performances of the Rab5-GFP 
rescue flies and TBPH mutants. Both groups averaged about 42 
141 
 
movements in 2minutes while those expressing Rab4-GFP and the 
control that was wildtype for TBPH  averaged about 68 and 100 
movements in the same time frame respectively Figure 53). 
 

























































Figure 53 Motility of larva was improved in TBPH mutant flies expressing Rab4-GFP. Larva 
peristaltic movements were observed and recorded in 120s for each larva. Rab4-GFP showed a 
significant rescue of motility compared with Rab5-GFP and TBPH mutant flies. Genotypes: Elav-gal4/+; 
UAS-Rab4-GFP/+ (Control), tbph∆23elav-gal4/tbph∆23; UAS-lacZ/+ (Tpbh mutant), tbph∆23elav-
gal4/tbph∆23; UAS-Rab5-GFP/+ (Rab5-GFP rescue)  and tbph∆23elav-gal4/tbph∆23; UAS-Rab4-
GFP/+ (Rab4-GFP rescue). N=25 per genotype. Error bars are SEM. ***p<0.0001, ns = not significant 
as calculated using ANOVA with Bonferroni’s correction. 
 
4.13.2 Rab5 expressed more than Rab4 at the NMJ in TBPH 
mutant flies 
Analysing the NMJ of both Rab4 and Rab5 GFP conjugated rescue 
larvae, we observed that the intensity of Rab5-GFP was significantly 
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higher than that of Rab4-GFP’s. However the higher expression level did 
not correlate with an increased phenotypic read out in motility (Figure 53 
Figure 54). The level of Rab5-GFP at 1.25 is almost double that of Rab4-
GFP at 0.73 (Figure 56) while the control with the expression of Rab4-
GFP in a TBPH wildtype background was 1.00. 
 















































Figure 54 The level of Rab5-GFP was higher in TBPH mutant flies. Panels are representative 
confocal images showing the NMJs between muscles 6 and 7 stained with anti- HRP (in red) and anti-
gfp (in green). Note the intensity of the Rab-gfp staining. Graph shows quantification of the Rab-GFP 
intensity in the boutons normalized on HRP. Genotypes: Elav-gal4/+; UAS-Rab4-GFP/+ (Control), 
tbph∆23elav-gal4/tbph∆23; UAS-Rab5-GFP/+ (Rab5-GFP rescue) and tbph∆23elav-gal4/tbph∆23; 
UAS-Rab4-GFP/+ (Rab4-GFP rescue). N=25 per genotype. Scale bar is 20µm. Error bars are SEM. 
***p<0.0001 as calculated using ANOVA with Bonferroni’s correction. 
 
4.13.3 Rab4 and Rab5 recovered Futsch levels at the NMJ in 
TBPH mutant flies 
Using IHC, we checked the level of Futsch at the NMJ in TBPH mutant 
flies expressing Rab4-GFP and Rab5-GFP given the recovery of motility 
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recorded with Rab4-GFP rescue flies. Both Rab proteins produced a 
recovery of Futsch levels at the NMJ (Figure 55). There was a significant 
difference in the intensities of Futsch measured in the control expressing 
Rab4-GFP in a TBPH wildtype background (1.00) compared with TBPH 
mutants expressing both Rab4-GFP and Rab5-GFP (about 0.90 and 0.87 
respectively). Both Rab rescue groups were significantly higher than 


























































Figure 55 The Rab proteins 4&5 recover Futsch level at the NMJ in TBPH mutant flies. Panel 
shows representative confocal images of the NMJs between muscles 6 and 7 double-labelled with anti- 
HRP (in red) and anti Futsch (in purple). Note the Futsch staining at the terminal bouton present in all 
the groups except in tbph mutant (white arrow). Graph shows quantification of Futsch intensity in the 
boutons normalized on HRP. Genotypes: Elav-gal4/+; UAS-Rab4-GFP/+ (Control), tbph∆23elav-
gal4/tbph∆23; UAS-Rab4-GFP/+ (Rab4-GFP rescue), tbph∆23elav-gal4/tbph∆23; UAS-Rab5-GFP/+ 
(Rab5-GFP rescue), and  tbph∆23elav-gal4/tbph∆23; UAS-lacZ/+ (Tpbh mutant). N= 25 per genotype. 





4.13.4 Rab4 and Rab5 improve the number of NMJ branches in 
TBPH mutant flies 
Also of note is the recovery of branches of the NMJ observed in both 
rescue groups of the Rab proteins. TBPH mutants expressing Rab4-GFP 
percentage number of branches averaged about 87% while those 
expressing Rab5-GFP had an average of 76%. Both groups have 
significantly higher percentage of branches than TBPH mutants with an 
average of 51%. The control expressing Rab4-GFP in a TBPH wildtype 
background was significantly higher than all other genotypes with a 100% 




















































Figure 56 The number of branches of the NMJ was improved in TBPH mutant flies expressing 
Rab proteins 4&5. Both rescue groups performed significantly better than TBPH mutant flies and a bit 
lesser than the control. NMJ was labelled with HRP. Genotypes: Elav-gal4/+; UAS-Rab4-GFP/+ 
(Control), tbph∆23elav-gal4/tbph∆23; UAS-Rab4-GFP/+ (Rab4-GFP rescue), tbph∆23elav-
gal4/tbph∆23; UAS-Rab5-GFP/+ (Rab5-GFP rescue), and  tbph∆23elav-gal4/tbph∆23; UAS-lacZ/+ 
(Tpbh mutant). N= 25 per genotype. Scale bar is 20µm. N=25 per genotype.  Error bars are SEM. 
***p<0.0001. * p<0.01 as calculated using ANOVA with Bonferroni’s corrections. 
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4.13.5 The level of acetylated tubulin at the NMJ was recovered 
in TBPH mutant flies expressing Rab4 or Rab5 
Having observed both the recovery of larva motility and that of Futsch at 
the NMJ of the Rab4-GFP rescue flies similar to that obtained with Futsch, 
we decided to check the level of acetylated tubulin at the NMJ in an 
attempt to make a connection between Futsch and Rab4. Figure 57 shows 
the results of the observations made. Indeed, there was a recovery of 
acetylated tubulin in TBPH mutant flies expressing Rab4-GFP and in 
those expressing Rab5-GFP with values averaging 0.91 and 0.93 
respectively. All genotypes averaged significantly higher intensities of 
acetylated tubulin than TBPH mutant flies expressing LacZ with a value of 
0.69. There was no statistical difference between the control expressing 
Rab4-GFP in a TBPH wildtype background with a value of 1.00 and both 


































































Figure 57 The level of acetylated tubulin was recovered in TBPH mutant flies expressing Rabs 
4&5. Panels are representative confocal images showing the NMJs between muscles 6 and 7 double-
labelled with anti-HRP (in green) and anti-acetylated tubulin (in red). Note the intensity of acetylated 
tubulin staining. Graph shows quantification of acetylated tubulin intensity in the boutons normalized on 
HRP. Genotypes: Elav-gal4/+; UAS-Rab4-GFP/+ (Control), tbph∆23elav-gal4/tbph∆23; UAS-Rab4-
GFP/+ (Rab4-GFP rescue), tbph∆23elav-gal4/tbph∆23; UAS-Rab5-GFP/+ (Rab5-GFP rescue), and  
tbph∆23elav-gal4/tbph∆23; UAS-lacZ/+ (Tpbh mutant). N= 25 per genotype. Scale bar is 20µm. N=25 
per genotype. Error bars are SEM. ***p<0.0001 as calculated using ANOVA with Bonferroni’s 
correction. 
 
4.13.6 The level of Syntaxin at the NMJ was not recovered in 
TBPH mutant flies expressing Rab4 or Rab5 
Syntaxin level at the NMJ was checked by IHC in TBPH mutant flies 
expressing Rab4-GFP and Rab5-GFP. No recovery of syntaxin was 
observed for both of the Rab proteins. TBPH mutant flies expressing LacZ 
had an average intensity of syntaxin of 0.82, while those expressing Rab4-
GFP and Rab5-GFP resulted in intensities of  0.83 and 0.81 respectively. 
The control expressing Rab4-GFP in a TBPH wildtype background was 
significantly higher than all other groups at an average of 1.00 (Figure 58). 
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Figure 58 The level of Syntaxin was not recovered in TBPH mutant flies expressing Rabs 4&5. 
Panels are representative confocal images showing the NMJs between muscles 6 and 7 double-labelled 
with anti-HRP (in green) and anti-syntaxin (in red). Note the intensity of syntaxin staining. Graph shows 
quantification of syntaxin intensity in the boutons normalized on HRP. Genotypes: Elav-gal4/+; UAS-
Rab4-GFP/+ (Control), tbph∆23elav-gal4/tbph∆23; UAS-Rab4-GFP/+ (Rab4-GFP rescue), 
tbph∆23elav-gal4/tbph∆23; UAS-Rab5-GFP/+ (Rab5-GFP rescue), and  tbph∆23elav-gal4/tbph∆23; 
UAS-lacZ/+ (Tpbh mutant). N=20 per genotype. Scale bar is 20µm. N=20 per genotype.  Error bars are 
SEM. ***p<0.0001 as calculated using ANOVA with Bonferroni’s correction. 
 
4.14 The level of pMad at the NMJ was reduced in TBPH mutant 
flies 
From the observations of recovery of the functional anatomy of the NMJ 
by Futsch, it was evident that Futsch promotes the growth of this 
specialised synapse. So, we decided to check its involvement in a growth 
signalling pathway and we chose the bone morphogenetic protein (BMP) 
growth signalling. Phosphorylated BMP pathway effector Mad (pMad) 
localizes to both the soma in the ventral cord (nuclear pMad) and the NMJ 
(synaptic pMad). While the role of the nuclear pMad is said to be 
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modulation of BMP target genes, that of synaptic pMad is yet to be fully 
understood and suggestions are made about a possible local synaptic 
activity rather than an involvement in retrograde translocation to the nuclei 
only.  



































Figure 59 The level of pMad was reduced in TBPH mutant flies. Panels are representative confocal 
images showing the NMJs between muscles 6 and 7 double-labelled with anti-HRP (in red) and anti-
pMad (in green). Note the intensity of pMad staining. Graph shows shows quantification of pMad 
intensity in the boutons normalized on HRP. Genotypes: w1118 (Control) and tbph mutant is tbph∆23/ 
tbph∆23. Scale bar is 20µm. N=25 per genotype.  Error bars are SEM. ***p<0.0001 as calculated using 
student t-test. 
 
Given this incitement, the levels of pMad was quantified at the NMJ of 
w1118 and TBPH mutant flies. There was a significant difference in the 
intensities of the pMad between the control and TBPH mutant flies  with 
averages of about 1.00 and 0.80 respectively (Figure 59). 
4.14 The level of pMad at the NMJ was improved in TBPH 
mutant flies expressing Futsch 
Having observed a significant difference in the intensities of the synaptic 
pMad between w1118 and TBPH mutant flies, we proceeded to check its 
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level in the Futsch rescue flies using TBPH rescue as a positive control 
(Figure 60). TBPH mutant flies expressing Futsch had an increased 
synaptic pMad level with a value of 0.85 when compared with those 
expressing GFP with a value of 0.78. The TBPH mutant flies rescued with 
TBPH and the control flies in a TBPH wildtype condition averaged 0.96 



















































Figure 60 The level of pMad was improved in TBPH mutant flies expressing futsch. Panels are 
representative confocal images showing the NMJs between muscles 6 and 7 double-labelled with anti-
HRP (in red) and anti-pMad (in green). Note the intensity of pMad staining. Graph shows quantification 
of pMad intensity in the boutons normalized on HRP. Genotypes: Elav-gal4/+ (Control), tbph∆23elav-
gal4/tbph∆23; UAS-GFP-mCD8/+ (Tpbh mutant), tbph∆23elav-gal4/UAS-tbph∆23 (Tbph rescue) and 
EP10751; tbph∆23elav-gal4/tbph∆23 (futsch rescue). Scale bar is 20µm. N=20 per genotype. Error bars 
are SEM. *p<0.01, **p<0.001, ***p<0.0001, ns = not significant as calculated using One-way ANOVA. 
 
4.15 The level of pMad at the NMJ was improved in TBPH 
mutant flies expressing Rab4 or Rab5 
We proceeded to check the level of pMad in the Rab-GFP rescue flies 
having observed a difference in the Futsch rescue flies. TBPH mutant flies 
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expressing Rab4-GFP gave a significant rescue of pMad at the NMJ with 
a value of 0.78 compared with the mutant flies expressing LacZ that had 
a value of about 0.70. Interestingly, the mutant flies expressing Rab5-GFP 
gave a higher rescue of pMad with a value of about 0.87 while the Control 
flies expressing Rab4-GFP in a TBPH wildtype background had a value 
of 1.00 (Figure 61). 
 






















































Figure 61 The level of pMad was improved in TBPH mutant flies expressing Rab proteins 4&5. 
Panels are representative confocal images showing the NMJs between muscles 6 and 7 double-labelled 
with anti-pMad (in green) and anti-HRP (in red). Note the intensity of pMad staining. Graph shows 
quantification of pMad intensity in the boutons normalized on HRP. Genotypes: is Elav-gal4/+; UAS-
Rab4-GFP/+ (Control), tbph∆23elav-gal4/tbph∆23; UAS-Rab4-GFP/+ (Rab4-GFP rescue), 
tbph∆23elav-gal4/tbph∆23; UAS-Rab5-GFP/+ (Rab5-GFP rescue) and tbph∆23elav-gal4/tbph∆23; 
UAS-LacZ/+ (Tpbh mutant). Scale bar is 20µm. N=15 per genotype. Error bars are SEM. *p<0.01, 






5.1 Silencing TBPH in neurons produced similar effects to its 
complete knockout with respect to Futsch functions 
Motility defect is a known classic feature of TBPH mutant flies reported by 
Feiguin et al., 2011 and Romano et al., 2014. On average, these larvae 
crawled less than half the number of times the wildtype flies did. So, we 
can say they have less than 50% motility function (Figure 31). Silencing 
TBPH in the neurons similar to a complete knockout, also produced an 
almost identical phenotype whereby the larvae crawled about half the 
number of times the control did. This implies that the larvae  having TBPH 
silenced in their neurons lost approximately 50% of their motility function 
which was sufficient to produce a significant defect. The observation of 
this ALS-like phenotype prompted further investigations into what the 
NMJs look like and whether the protein level and the localization of Futsch 
was affected or not, considering that Futsch is a known translational target 
of TBPH (Coyne et al., 2014). Futsch was found to be about 22% reduced 
at the NMJ and this difference was sufficient to elicit “Futsch” dysfunction 
because the number of branches and boutons were also reduced and 
importantly the shape of the boutons were also affected (Figure 34,Figure 
32 and Figure 33). These features are all those associated with reduced 
Futsch levels as seen in TBPH mutant flies. Also, of note is the distribution 
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of Futsch which was ominuously absent in the terminal boutons when 
TBPH was silenced (Figure 34). This is an important observation because 
growth occurs at the terminal boutons and Futsch is required to stabilize 
the microtubule cytoskeleton responsible for the maintenance of the 
shape of both old and newly formed boutons in order to maximise their 
functions (Roos et al., 2000) and efficacy. 
5.2 Futsch recovered motility in TBPH mutant flies best with 
Elav-gal4 
Pan neuronal driver Elav-gal4 was found to be the best driver for the 
expression of Futsch in the neurons of TBPH mutant flies. This conclusion 
was drawn from observations made from the results of the larva 
movements carried out using different drivers (Figure 35Figure 36) from 
which Elav-gal4 gave the highest numerical value of recovery. nSyb-gal4, 
another pan neuronal driver also performed significantly better than the 
motor neuron specific drivers but Elav-gal4 scored higher (Figure 35). One 
may be tempted to think that D42-gal4 and OK6-gal4 should perform 
better since they are motor neuron drivers and are directly involved in the 
disease (having a localised effect on ALS) but this was not the case as 
reported from the observations made. Indeed, the reverse was the case 
with the pan neuronal drivers performing better than the motor neuron 
specific drivers. We attributed this to the probable multiple roles of Futsch. 
It could be responsible for the availability of other important proteins and 
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factors involved in different pathways in the neuronal system in addition 
to its relationship with TDP-43. So, using a driver with a broader spectrum 
of functions not limited to only the motor neurons may make available 
these “factors” hence, a better functional read-out was obtained. 
Importantly, Elav-gal4 is tested and trusted because it is known as one of 
the most commonly used and reliable driver for gene expression in the 
nervous system. Thus, its performance here was not surprising and 
unexpected (Shiraishi et al., 2014). 
Irrespective of the driver used for the gene expression, it was clear that 
Futsch produced a rescue of an important phenotypic defect of TBPH 
mutant flies, locomotion (here observed as larva motility). This was an 
impressive feat because even the motor neuron drivers when used were 
able to exert a positive effect on motility implying a very cogent action of 
Futsch in the neurons. How and what exactly Futsch did in TBPH mutant 
larvae to elicit a recovery of motility dysfunction remained an important 
subject of the project. 
5.3 Futsch recovered NMJ abnormalities associated with 
microtubules and synaptic growth in TBPH mutant flies 
Hummel et al., 2000 demonstrated Futsch to be important for axonal and 
dendritic growth. NMJ abnormalities seen in TBPH mutant flies such as 
mis-shaped boutons, reduced number of branches and bouton’s number 
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(Feiguin et al., 2009) were recovered by expressing Futsch in their 
neurons. Some criteria by which growth is quantified at the NMJ include 
shape of boutons, and number of branches and boutons among others. 
Roos et al., 2000 reported Futsch to be necessary for synaptic growth in 
Drosophila. Godena et al., 2011 and Coyne et al., 2014 demonstrated a 
connection between TDP-43 and Futsch at the NMJ by reporting a 
decrease in Futsch level in TBPH mutant flies and in the spinal cords of 
ALS patients respectively. An observation that is corroborated by this 
study too (Figure 30). 
It is generally accepted that development and growth at the NMJ occur by 
addition and stabilization of new boutons through division of old boutons. 
A function regulated by the microtubule cytoskeleton as they are important 
for synaptic organization and plasticity. Futsch has been found to be 
necessary for the maintenance of this process thereby controlling growth 
at the NMJ (Roos et al., 2000) More so, the shape of the boutons is 
important not only for growth but also for synaptic functions related to their 
surface area such as neurotransmission, thus it is important for optimal 
functioning of the specialized synapse. All of which are regulated by the 
microtubule cytoskeleton that are responsible for the maintenance of the 
architecture necessary to stabilize the boutons during division. Normal 
Futsch function is important for smooth running of this process. So, our 
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observations of a recovery of synaptic growth in TBPH mutant flies 
expressing Futsch with respect to boutons and branches (Figure 37Figure 
38), expands and substantiate the claims of Godena et al., 2011 and is in 
direct accordance with available literature. The overall integrity and 
stabilization of the NMJ appear to be regulated by Futsch but not only by 
virtue of its association with the microtubule cytoskeleton. If this were to 
be singularly so, we should observe similar effects when another 
microtubule associated protein is substituted for Futsch in the quest of 
locomotion rescue. Tau is a MAP that belongs to the same classical group 
as Futsch and expressing Tau in the neurons of TBPH mutant flies failed 
to produce a recovery of motility in the larvae. A sharp contrast to what 
was observed with Futsch. Interestingly, Tau also gave a recovery of the 
anatomy of the NMJ but it was not enough to translate into a functional 
phenotype (Figure 39). We therefore believe that Futsch is probably 
involved in another pathway that may not be directly related with its status 
as a microtubule associated protein as there is a level of functional 
redundancy in the MAPs which Tau was not able to replicate here.   
5.4 Microtubules were more stabilized at the NMJ of TBPH 
mutant flies when Futsch was expressed in their neurons 
Recovery of functions involving stable microtubules such as branches and 
bouton shapes made it imperative to check the level of stabilized 
microtubules. Acetylation is a key post translational modification of tubulin 
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and is widely accepted as a measure of stability. A good recovery of 
acetylated tubulin, consequently, stable microtubules was observed with 
neuronal Futsch overexpression in TBPH mutant flies which confirms the 
functional MAP action of Futsch (Figure 43). In line with the reported lower 
levels of Futsch in these flies, Godena et al., 2011 also observed a 
concurrent reduction in the quantity of their synaptic “stable” (acetylated) 
microtubules. Worthy of note was the distribution of the “stable” 
microtubules that were recovered with TBPH expression. They were 
present in the terminal boutons where Futsch was also found but they 
were ominously absent in the TBPH mutant flies (Figure 43). This reiterate 
the importance of Futsch function in the maintenance of bouton stability 
and overall NMJ growth. This result obtained with acetylated tubulin by 
Futsch was indeed quite important as it gave more than probable 
credence to the previously obtained results because now we have a direct 
link of Futsch to the microtubules in its recovery quest. 
5.5 The levels of pre-synaptic vesicular proteins were recovered 
by Futsch in TBPH mutant flies 
Having observed the recovery of motility and overall integrity of the NMJ 
in TBPH mutant flies by Futsch,  we were curious to understand how 
futsch was able to do this especially when another MAP, Tau, was not 
able to exert such a functional recovery. So, we decided to check the 
levels of some presynaptic proteins involved with synaptic vesicles to gain 
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an insight into the direction through which Futsch follows to elicit this 
recovery. Given the fact that it also recovered stable microtubules that are 
known as the ‘highway’ for cellular transportation. Could the overall 
functional readout of improved motility be a result of better synaptic output 
by way of more efficient synaptic vesicles and trafficking? 
Synapsin, Syntaxin and CSP are all proteins involved with synaptic 
vesicles. All of these proteins were downregulated at the NMJ of TBPH 
mutant flies (Romano et al., 2014) and we found that Futsch was able to 
recover them to significantly appreciable levels. Synapsins are neuron-
specific phosphoproteins that have been implicated in the clustering of 
synaptic vesicles especially those in the ‘reserve pool’ (Hilfiker et al., 
1999). They are known to interact with the vesicles and the cytoskeletal 
architecture thereby keeping the vesicles together in readiness for 
exocytosis to sustain neurotransmission. (Winther et al., 2015) confirmed 
the clustering action of synapsin at the Drosophila NMJ in a synergistic 
association with dap160, a protein also involved in synaptic vesicle 
tethering. Genetic studies involving the NMJs of C. elegans and D. 
melanogaster revealed syntaxin to be involved in a trimeric SNARE 
(soluble N-ethylmaleimide sensitive factor attachment receptor) complex 
that is necessary for priming of synaptic vesicles. The complex is formed 
by synaptobrevin, syntaxin and SNAP-25 (soluble N-ethylmaleimide 
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sensitive factor attachment protein 25) (Richmond & Broadie, 2002) and 
is thought to drive the process of exocytosis. Romano et al., 2014 reported 
a possible translational connection between syntaxin and TBPH implying  
that the reduction we see in the levels of syntaxin at the NMJ could also 
play a role in the synaptic defects seen in TBPH mutant flies. It is pertinent 
to note that Futsch has also been reported as a translational target of 
TBPH (Coyne et al., 2014). Cysteine string protein (CSP) is also involved 
with the synaptic vesicles and it functions to maintain the spatial 
arrangement of SNAP 25 to enhance its recruitment into the SNARE 
complex at the membrane ready for fusion (Burgoyne & Morgan, 2015). 
Futsch recovery of these downregulated synaptic vesicle proteins in 
TBPH mutant flies (Figure 40Figure 41 Figure 42) prompted us to proceed 
in the direction of the synaptic vesicle recycling as a probable means or 
part of the mechanism involved by which Futsch exert its rescue of ALS-
like motility defects. Before we check the synaptic vesicle recycling, it 
made good sense to check the level of some post-synaptic proteins too 
since all these vesicular proteins are pre-synaptic.   
5.5 Post synaptic proteins Dlg and GluRIIA were recovered by 
Futsch in TBPH mutant flies 
TBPH was found to be necessary for the organization and maintenance 
of post synaptic structures at the neuromuscular junction. Strah et al., 
2020 reported an interaction between TBPH and the mRNA of Dlg 
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implying a regulatory function on its expression level both in neurons and 
skeletal muscles. In accordance with this report, we have also observed 
a reduction in the level of Dlg at the NMJ of TBPH mutant flies (Figure 44) 
which gives credence to the report of a concomitant reduction of its mRNA 
levels in this same flies. Why Futsch, a microtubule associated protein 
recovers this Dlg reduction in TBPH mutant flies is probably due to the 
fact that Futsch is necessary for the growth and maintenance of axons 
and dendrites which are important for neurotransmission from the pre to 
the post synaptic compartments for effective functioning. Also of note, 
both proteins were found to be downregulated in ALS patients (Coyne et 
al., 2014; Strah et al., 2020) and TBPH exerts a regulatory action on them 
so, this can also have a contributory role in the mechanism. Post synaptic 
clustering of glutamate receptors is important to maintain transmission at 
the synapse (Romano et al., 2018). They reported glutamic acid 
decarboxylase (Gad1) to be required for the clustering of GluRIIA at the 
NMJ as GluRIIA was found to be reduced in TBPH mutant flies. 
Furthermore, they observed a higher level of extracellular glutamate 
levels. We also observed a reduction in the clusters of post synaptic 
GluRIIA  at the NMJ in TBPH mutant flies (Figure 45) which is in 
agreement with the glutamate excitotoxicity theory (as a result of reduced 
glutamate receptors) as a contributory mechanism of ALS disease and 
progress. Futsch probably improves the clustering of these receptors via 
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similar mechanism by which it is involved in the clustering of synaptic 
vesicles for efficient neurotransmission. 
5.6 More mitochondria were localized at the NMJ of TBPH 
mutant flies   
The role of mitochondria dysfunction in the pathogenesis of ALS and other 
TDP-43 proteinopathies has been discussed. Recently, Wang et al., 2019 
reported ultrastructural damages to the mitochondria along with functional 
impairments in TDP-43 proteinopathies using a combination of cell and 
animal model systems while comparing with samples from patients. 
Damage to this organelle has been reported to precede motor neuron 
degeneration (also in SOD1 mouse model) making its intervention a 
potential therapeutic target. Interestingly, we observed that the intensity 
of mito-GFP (a mitochondrial import signal fused to GFP) was higher in 
TBPH mutants (Figure 46) when compared with the wildtype. This could 
be because more mitochondria are transported to the NMJ to compensate 
for the inefficiency of the synapse as they are mainly responsible for 
providing the energy required to maintain the synaptic processes that are 
majorly active. So, we can tentatively say that the transport of 
mitochondria to the NMJ in TBPH mutant flies appear to be unaffected by 
the loss of TBPH and Futsch while the reverse is the case for synaptic 
vesicles. Unfortunately, nothing can be postulated regarding the efficient 
functioning of the mitochondria at NMJs since the use of mito-GFP only 
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allows the quantification and presence of mitochondria. The higher mito-
GFP intensity detected at the NMJ of TBPH mutants could be due to their 
inability to move quickly or freely back to the soma with a consequent 
backlog of inefficient and/ old mitochondria that should be degraded that 
translate into a higher intensity of mito-GFP reported in TBPH mutants.   
5.7 Futsch has a role in synaptic vesicle recycling in TBPH 
mutant flies 
The use of FM1-43 dye to demonstrate synaptic vesicle recycling at the 
NMJ in Drosophila larvae provides a good method to gain an insight into 
the workings of vesicular trafficking at the synapse and its role in effective 
neurotransmission. In order to sustain neurotransmission, an efficient 
recycling of vesicles has to take place (Verstreken et al., 2008).  Having 
recovered through Futsch the expression level of some proteins 
associated with synaptic vesicles, it was a further positive confirmation to 
observe that also the impaired synaptic vesicle recycling in TBPH mutant 
flies (Figure 51) was rescued by Futsch.  A complete vesicle cycle 
includes both exocytosis and endocytosis. Regarding exocytosis, Futsch 
was found to be necessary for normal neurotransmitter (glutamate) 
release and maintenance of active zones in Drosophila (Lepicard et al., 
2014). These authors observed a reduction in the amplitude of evoked 
excitatory junctional currents (eEJC) in Futsch mutants and proposed a 
reduction in the mean number of synaptic vesicles released upon 
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stimulation as a causative factor. This is because they did not observe 
any changes in the spontaneous synaptic vesicle release as measured by 
the miniature excitatory junctional currents’ (mEJC) amplitude and 
frequency. So, they concluded that loss of Futsch causes a presynaptic 
dysfunction in glutamate release at the NMJ in Drosophila as a 
consequence of a decreased number of vesicles in the readily releasable 
pool (RRP). Expressing Futsch in the neurons of TBPH mutant flies was 
probably able to rescue this pre-synaptic defect of reduced vesicular 
release thereby improving the turnover of the recycling process (Figure 
51). This can also make available “synapsin” that is responsible for 
clustering these vesicles in the pool keeping them together and making 
them available upon stimulation. All of these, consequently make the 
synapse (NMJ) more efficient in its function and could translate 
phenotypically as improved motility. Worthy of mention is also the 
recovery of these “sub-boutonic structures” which contained sequestered 
FM1-43 clearly detectable by  its high intensity there (Figure 52). Even if 
it is not yet clear what these structure are, and further studies are 
necessary to elucidate their functions, what came to light is the fact that, 
since FM1-43 labels vesicles, they contain more vesicles than elsewhere 
in the boutons. Could this sub-boutonic structures contain vesicles in the 
readily releasable pool (RRP)? Given that reduction of vesicles in the RRP 
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has been observed to be a consequence of Futsch absence (Lepicard et 
al., 2014). 
5.8 Neuronal expression of the Rab4 and Rab5 recovers some 
TBPH mutant flies defects 
The Rab family of GTPases is a family of endosomal proteins important 
as regulators of endosomal trafficking. Rab4 and Rab5 are localized to 
the early endosomes and they have roles in recycling of internalised 
vesicles and endosomal fusion respectively. While Rab4 has been 
implicated in the control of vesicle recycling from the early endosomal 
compartment to the recycling compartment and back to the plasma 
membrane, Rab5 is thought to regulate the initial transport of Clathrin-
coated vesicles from the plasma membrane to the early endosomes, their 
tethering and eventual fusion (Zerial & McBride, 2001). 
Microtubule-dependent motor proteins transport vesicles including the 
Rabs from the Golgi apparatus to various parts of the cell where they are 
required. There is a conserved machinery of Kinesin-Rab interaction from 
mammalian cells to Drosophila. Early endosomes with Rab5 associate 
with Khc-73 (mammalian KIF13) and Dynein while vesicles associated 
with Rab4 interact with Kinesin-2 and 3 (Dey et al., 2017) These 
interactions imply that the Rab proteins travel along the microtubule-
dependent pathway bidirectionally (both retrograde and anterograde) so, 
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it was not very surprising to find that the expression of Rab4 in the neurons 
of TBPH mutant flies recovered motility (Figure 53) and acetylated tubulin 
levels (Figure 57) similar to those obtained when Futsch, a microtubule 
associated protein was expressed in the same flies.  This is because Rab4 
transport on the Futsch-dependent stable microtubules provides a 
plausible point of contact for signalling between the two proteins which 
could explain their similar rescue patterns. Also of note is the fact that the 
NMJ branching was also improved by both proteins (Figure 56). It was 
interesting to see that expressing either Rab4 or Rab5 in the neurons of 
TBPH mutant flies was sufficient to recover the levels of Futsch at the 
NMJ (Figure 55). This observation of Futsch recovery made the motility 
rescue in the larvae and branching of the NMJ observed in the Rab-GFP 
rescue flies understandable. On the contrary, Dey et al., 2017 found that 
reduced flow of Rab4-positive vesicles to the ventral ganglion of the larva 
enhanced motility although not in a TBPH mutant background. The 
relationship between Futsch and the Rab proteins appears to be 
microtubule related for the main purpose of transport as the Rab proteins 
were also able to recover the levels of acetylated tubulin which is a marker 
of stable microtubules, the generic function of Futsch. It is however 
interesting to observe that Rab4 was also able to recover the level of 
pMad, an effector in the BMP signalling pathway in a manner similar to 
that of Futsch (Figure 60Figure 61) which was mildly significant but 
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apparently enough to exert a direly needed physiological response and 
rescue. We therefore speculate, that these two proteins (Futsch and 
Rab4) seems to be required in a similar tightly controlled levels and are 
involved in a  biological process(es) devoid of Rab5. Why Rab4 and not 
Rab5 was able to recover motility in TBPH mutant flies is still obscure. 
Could it be that Rab4 is more effective in its action of balancing the 
vesicular traffic between the recycling and degradation pathways? This 
action is quite important for the maintenance of general metabolism and 
special cellular features such as secretion and transmission. Indeed, both 
Rab proteins recovered the level of Futsch and pMad and even though, 
Rab5-GFP’s level was almost double the level of Rab4-GFP when 
expressed in the TBPH mutant flies (Figure 54), its phenotypic readout of 
motility was not recovered and its larvae retained their motility defects 
similarly to the TBPH mutant flies (Figure 53).  
5.9 Futsch improved the level of synaptic pMad  in TBPH 
mutant flies 
Phosphorylated mad is an important component of the BMP signalling 
pathway without which the growth signal coming from the muscle does 
not reach the nucleus of the connecting motor neuron. Mothers against 
dpp, (Mad) is phosphorylated by the BMP receptors wishful thinking (wit), 
saxophone (sax) and thickvein (tkv) upon receiving the glass boat bottom 
(gbb) signal from the underlying muscle. This in turn forms a complex with 
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medea (Medea) that facilitates translocation to the nucleus where it 
modulates the expression of target genes in the motor neuron (Aberle et 
al., 2002; Marqués et al., 2002; McCabe et al., 2003; Rawson et al., 2003). 
Loss of BMP signalling has been shown to alter Futsch distribution in 
motor neurons (Ellis et al., 2010). Consistent with this claim is the 
observed mild but significant recovery of this BMP transducer that is 
significantly lost in TBPH mutant mutants by Futsch (Figure 60). 
Deshpande et al., 2016 also reported a dramatic loss of pMad in TBPH 
mutants which is in accordance with reduced synaptic BMP signalling. Of 
note are previous works documenting Futsch as a key player in synaptic 
growth through its effect on microtubule network and stability (Roos et al., 
2000, Hummel et al., 2000, Godena et al., 2011).  Also reported is a direct 
link between loss of microtubule stability and synaptic growth which 
presupposes a direct action for Futsch, a known microtubule stabilizer. A 
Futsch-dependent regulation of microtubule stability as a main target for 
BMP signalling in the regulation of synaptic growth has been proposed 
(Nahm et al., 2013). Nahm and colleagues observed that dysregulated 
BMP signalling manifesting as synaptic growth defects were totally 
suppressed by Futsch mutations. They showed Drosophila fragile x 
mental retardation protein (dFMRP), a translational repressor of Futsch 
(Zhang et al., 2001) acts downstream of BMP signalling to modulate the 
levels of Futsch which is tightly regulated to maintain microtubule stability 
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and in effect, neuronal viability. Although, the modulation of synaptic 
growth by Futsch was shown to be regulated by the BMP signalling 
pathway, the strength of the synaptic transmission was observed to be 
devoid of Futsch action (Ball et al., 2010). 
5.10 The interplay of vesicle recycling, Futsch and the BMP 
signalling in dTDP-43’s  ALS 
TDP-43-induced synaptic growth defects are similar to those observed in 
reduced BMP signalling at the NMJ such as reduced bouton number and 
size (Rawson et al., 2003). Its mis-regulation heavily affected the synaptic 
BMP signalling but not the nuclear BMP signalling. This indicates that the 
signalling defect occur upstream of Mad as a negative regulator of Mad 
(Dad) was able to suppress the NMJ’s growth reductions induced by 
dTDP-43 (Deshpande et al., 2016). Could TDP-43 also be a target of the 
BMP signalling? It is possible that the actions of dFMRP and TDP-43 on 
Futsch could be opposingly synergistic depending on the modulatory 
signaling of the BMP (Figure 62). 
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Figure 62 Schematic of a proposed BMP signalling model at the Drosophila NMJ. This supports 
a model where TBPH and dFMRP exerts an opposing synergistic effect on futsch to modulate 
microtubule stability and synaptic growth at the NMJ resulting in improved locomotion. Rab4 may act 
as a sensor for Futsch to modulate this action or Futsch may be a sensor for Rab4 to regulate 
endosomal trafficking rate to improve function. Future studies will be aimed at making this clarification. 
 
A non-canonical role for synaptic pMad was proposed by (Sulkowski et 
al., 2014). They suggested that the BMP signalling pathway monitors 
synaptic activity to adjust growth through the monitoring of  presynaptic 
“BMP receptors-pMad dependent complexes” and the activities of post 
synaptic glutamate receptors IIA without requiring any gbb signal. So, 
synaptic pMad acts like a ‘sensor’ for the BMP signalling to adjust the 
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synaptic growth accordingly (Sulkowski et al., 2014). GluRIIA was 
significantly reduced in TPBH mutant flies which apparently corelates with 
reduced synaptic pMad, a measure of reduced BMP signalling. Futsch 
was able to improve the level of GluRIIA when expressed in the neurons 
of TBPH mutant flies. This gives us another possible pathway Futsch may 
be involved in. 
Traffic through the recycling endosomes was shown to be required to 
decrease BMP signalling and TDP-43 caused a loss of this signal by 
sequestrating BMP receptors from early to recycling endosomes 
(Deshpande et al., 2016). This could explain why Rab4 involved in the 
regulation of the early-recycling-degradation pathway was able to recover 
motility of TBPH mutant larva and Rab5 involved in endocytic budding did 
not, given their respective actions. Futsch could be interacting with Rab4 
to increase the recycling rate of the BMP receptors or even its ligand. More 
studies are in order to uncover this important link. 
Data from the mammalian systems also suggest BMP signalling as a 
regulator of MAPs, a group into which Futsch (MAP1B) belongs. Using 
mammalian neuron cultures, BMP7 (mammalian homologue of 
Drosophila gbb) has been described as a regulator of microtubule 
stabilization through the phosphorylation of MAP2 (Podkowa et al., 2010; 
Withers et al., 2000). Similar report was given by (Björkblom et al., 2005) 
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where MAP2 was implicated as an effector of the JUN kinase 1 enzyme 
in the maintenance of dendritic architecture. Spichthyin (NIPA1), Spastin 
and Spartin are proteins involved in the neurodegenerative disease, HSP 
(hereditary spastic paraplegia) and are localized to endosomes. They 
have been found to be inhibitors of the BMP signalling pathway both in 
Drosophila and mammalian systems (Nahm et al., 2013; Tsang et al., 
2009; Tsang et al., 2007). This is through their regulatory roles in the 
internalization and endosomal trafficking of BMP receptors. Thus, a 
common role of pathological importance for BMP signalling in various 
neurodegenerative diseases is presumable. 
In a Drosophila model of ALS, (Ratnaparkhi et al., 2008) observed a 
corresponding loss of pMad when VAPB (vesicle associated protein B) 
level was reduced and vice versa. Also, the level and distribution of Futsch 
was also impaired in VAP mutants suggesting a direct effect on 
microtubules. VAP levels were found to be reduced in ALS patients and 
mutant SOD transgenic mice (Teuling et al., 2007). Smad (Mad) has been 
reported to bind directly to microtubules and only dissociate to return to 
the nucleus upon the microtubules undergoing phosphorylation (Dong et 
al., 2000). (Wang et al., 2007) found that BMP signalling is required for 
microtubule stability in motor neurons and loss of tkv (Thickvein) resulted 
in defective microtubules and reduced tubulin. So, all of these taken 
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together gives credence to the observation of Futsch recovering not only 
synaptic proteins but also vesicle recycling and a BMP effector protein all 
of which are deficient in our TDP-43 model of ALS. 
Evidence that the BMP signalling may be impaired in human ALS patients 
is gradually coming to light. A report by (Nakamura et al., 2008) showed 
a significant reduction in the levels of nuclear pSmad and also found 
cytoplasmic round hyaline inclusions containing sequestrated pSmad. 
These are reported in specimens of motor neurons from human sporadic 
ALS spinal cords. So, upregulating the BMP signalling in the neurons 
through Futsch and Rab4 actions seems to be a viable therapeutic 
scheme of action worthy of future pursuit. 
Research into identifying biomarkers of ALS progression in humans 
yielded smad 1, 3, and 8 (Mad in Drosophila) as biomarkers of disease 
progression in the skeletal muscles harvested from a cohort of ALS 
patients. This was confirmed using the SOD1 mouse model (Yi et al., 
2014). Also, identified is the TGF-beta (gbb in Drosophila) family of ligand 
in the muscles as a marker of disease progression. This, the authors 
confirmed using the C2C12 muscle cell lines (Yi et al., 2015). Their results 
corelated with an increase in the expression and levels of the ligand, the 
described smads, and muscle weakness in ALS patients as the disease 
progresses. So, the smads and the TGF-beta ligand are viable as 
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biomarkers that could predict ALS disease progression in humans. This is 
an important feat because it provides a good diagnostic approach into 
discovering the disease early before clinical symptomatic manifestations 
















6.0 Conclusions and Recommendations 
6.1 Conclusions 
The discovery of mutations in proteins associated with microtubule 
organization and stability in human diseases such as ALS, Hereditary 
spastic paraplegias, fragile X mental retardation, among others (Ellis et 
al., 2010) gave credence to the stature of microtubule wholeness in 
neuronal function. BMP signalling has been implicated in the maintenance 
of microtubule architecture (Wang et al., 2007). In characterizing the role 
of Futsch/MAP1B in the rescue of locomotion defects in a TDP-43 model 
of ALS, we were able to observe and understand that Futsch is important 
in a variety of processes at the neuromuscular junction. TBPH mutants, 
our model of ALS have major dysfunctions in Futsch levels and 
distribution, microtubule stability and in processes involving stable 
microtubules such as axonal transport. Futsch expression was able to 
resolve this microtubule defect and other synaptic proteins loss thus, 
enhancing the viability of the motor neurons probably through a more 
active and effective BMP signalling response resulting from improved 
vesicle recycling of its receptors. This is presumably one of the reasons 
why expressing Futsch in the neurons of TBPH mutant flies was sufficient 
to significantly recover one of the major symptoms of the disease that is a 
direct read-out of motor neuron degeneration, defective locomotion. 
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Targeting endosomal trafficking of the BMP receptors/effectors remain a 
future therapeutic target to return the growth signalling function as there 
is observed recycling defects in TDP-43 induced ALS which was improved 
by Futsch expression. So, Futsch is also another probable candidate for 
therapeutic tests. 
6.2 Some recommendations 
Listed below are some of the experiments that we would be interested to 
perform to deeply investigate the relationship of Futsch, vesicle recycling 
and the BMP signalling.  
• It would be interesting to see if Futsch recovers the levels of Rab4 
as Rab4 was able to significantly improve its levels. 
• Further experiments are required to test the localization of Rab4 in 
the boutons at the NMJ preferably using the FM1-43 dye protocol. 
It would be interesting to see their co-localization on live imaging. 
• The unravelling of the exact nature of the sub-boutonic structures 
observed is also worthy of future pursuits.  
• In addition, more experiments are required to test Futsch and Rab4 
recovery of BMP receptors and transducers preferably using their 
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